<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article" dtd-version="1.3">
  <?properties open_access?>
  <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
    <restricted-by>pmc</restricted-by>
  </processing-meta>
  <front><journal-meta><journal-id journal-id-type="nlm-ta">Cell Insight</journal-id><journal-id journal-id-type="iso-abbrev">Cell Insight</journal-id><journal-title-group><journal-title>Cell Insight</journal-title></journal-title-group><issn pub-type="epub">2772-8927</issn><publisher><publisher-name>Elsevier</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">38250017</article-id><article-id pub-id-type="pmc">10797155</article-id><article-id pub-id-type="pii">S2772-8927(23)00067-6</article-id><article-id pub-id-type="doi">10.1016/j.cellin.2023.100143</article-id><article-id pub-id-type="publisher-id">100143</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Evasion of host defense by <italic>Brucella</italic></article-title></title-group><contrib-group><contrib contrib-type="author" id="au1"><name><surname>Yang</surname><given-names>Jinke</given-names></name></contrib><contrib contrib-type="author" id="au2"><name><surname>Wang</surname><given-names>Yue</given-names></name></contrib><contrib contrib-type="author" id="au3"><name><surname>Hou</surname><given-names>Yuanpan</given-names></name></contrib><contrib contrib-type="author" id="au4"><name><surname>Sun</surname><given-names>Mengyao</given-names></name></contrib><contrib contrib-type="author" id="au5"><name><surname>Xia</surname><given-names>Tian</given-names></name></contrib><contrib contrib-type="author" id="au6"><name><surname>Wu</surname><given-names>Xin</given-names></name><email>wuxin@caas.cn</email><xref rid="cor1" ref-type="corresp">&#x2217;</xref></contrib><aff id="aff1">State Key Laboratory for Animal Disease Control and Prevention, College of Veterinary Medicine, Lanzhou University, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou, 730000, China</aff></contrib-group><author-notes><corresp id="cor1"><label>&#x2217;</label>Corresponding author. <email>wuxin@caas.cn</email></corresp></author-notes><pub-date pub-type="pmc-release"><day>17</day><month>12</month><year>2023</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.--><pub-date pub-type="collection"><month>2</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>17</day><month>12</month><year>2023</year></pub-date><volume>3</volume><issue>1</issue><elocation-id>100143</elocation-id><history><date date-type="received"><day>23</day><month>10</month><year>2023</year></date><date date-type="rev-recd"><day>11</day><month>12</month><year>2023</year></date><date date-type="accepted"><day>11</day><month>12</month><year>2023</year></date></history><permissions><copyright-statement>&#xA9; 2023 The Authors</copyright-statement><copyright-year>2023</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).</license-p></license></permissions><abstract id="abs0010"><p><italic>Brucella</italic>, an adept intracellular pathogen, causes brucellosis, a zoonotic disease leading to significant global impacts on animal welfare and the economy. Regrettably, there is currently no approved and effective vaccine for human use. The ability of <italic>Brucella</italic> to evade host defenses is essential for establishing chronic infection and ensuring stable intracellular growth. <italic>Brucella</italic> employs various mechanisms to evade and undermine the innate and adaptive immune responses of the host through modulating the activation of pattern recognition receptors (PRRs), inflammatory responses, or the activation of immune cells like dendritic cells (DCs) to inhibit antigen presentation. Moreover, it regulates multiple cellular processes such as apoptosis, pyroptosis, and autophagy to establish persistent infection within host cells. This review summarizes the recently discovered mechanisms employed by <italic>Brucella</italic> to subvert host immune responses and research progress on vaccines, with the aim of advancing our understanding of brucellosis and facilitating the development of more effective vaccines and therapeutic approaches against <italic>Brucella</italic>.</p></abstract><kwd-group id="kwrds0010"><title>Keywords</title><kwd><italic>Brucella</italic></kwd><kwd>Innate immunity</kwd><kwd>Adaptive immunity</kwd><kwd>Virulence factors</kwd><kwd>Immune evasion</kwd></kwd-group></article-meta></front>
  <body>
    <sec id="sec1">
      <label>1</label>
      <title>Introduction</title>
      <p id="p0010">Brucellosis is a significant zoonotic disease caused by <italic>Brucella</italic> species, widely distributed worldwide (<xref rid="bib14" ref-type="bibr">Buttigieg et&#xA0;al., 2018</xref>; <xref rid="bib39" ref-type="bibr">Godfroid et&#xA0;al., 2005</xref>). In human, <italic>Brucella</italic> infection leads to symptoms including undulant fever, arthritis, endocarditis, and meningitis, with a prolonged and recurring course that negatively impacts workforce productivity. In animals, brucellosis results in abortion and infertility, posing substantial threats and economic losses to both public health and the agricultural industry (<xref rid="bib88" ref-type="bibr">Moreno, 2014</xref>). Notably, the disease is prevalent in pastoral regions and has gradually spread from occupational to non-occupational populations in recent years during the transition from pastoral to non-pastoral areas (<xref rid="bib92" ref-type="bibr">Pappas, 2010</xref>; <xref rid="bib93" ref-type="bibr">Pappas, Papadimitriou, Akritidis, Christou, &amp; Tsianos, 2006</xref>). At present, there is no internationally recognized safe and effective human vaccine against <italic>Brucella</italic> (<xref rid="bib45" ref-type="bibr">Heidary et&#xA0;al., 2022</xref>).</p>
      <p id="p0015"><italic>Brucella</italic> is an aerobic, gram-negative bacteria that exhibits a partially intracellular parasitic form, characterized by a short or coccobacillary morphology (<xref rid="bib39" ref-type="bibr">Godfroid et&#xA0;al., 2005</xref>). Based on variances in pathogenicity and host specificity, the genus <italic>Brucella</italic> is classified into 6 species and 19 biotypes, with <italic>B.&#xA0;melitensis</italic>, <italic>B.&#xA0;abortus</italic>, and <italic>B.&#xA0;suis</italic> posing significant threats to human (<xref rid="bib33" ref-type="bibr">Eisenberg et&#xA0;al., 2012</xref>; <xref rid="bib34" ref-type="bibr">Eisenberg et&#xA0;al., 2017</xref>; <xref rid="bib54" ref-type="bibr">Im, Jung, Shin, Kim, &amp; Yoo, 2016</xref>). <italic>Brucella</italic>'s pathogenicity mainly stems from its ability to evade host defense system and survive long-term within specialized phagocytes such as macrophages and dendritic cells (DCs), as well as placental trophoblast cells (<xref rid="bib22" ref-type="bibr">Copin et&#xA0;al., 2012</xref>; <xref rid="bib82" ref-type="bibr">Martirosyan &amp; Gorvel, 2013</xref>). The virulence factors of <italic>Brucella</italic> include lipopolysaccharide (LPS), flagellum, the type IV secretion system (T4SS) and outer membrane proteins (Omps) (<xref rid="bib20" ref-type="bibr">Coloma-Rivero et al., 2021</xref>; <xref rid="bib41" ref-type="bibr">Gorvel &amp; Moreno, 2002</xref>; <xref rid="bib99" ref-type="bibr">Roop, Barton, Hopersberger, &amp; Martin, 2021</xref>). The T4SS secrets effector proteins into host cells to evade host immune responses and promote <italic>Brucella</italic> replication, leading to persistent chronic infections in host cells (<xref rid="bib138" ref-type="bibr">Xiong et&#xA0;al., 2021</xref>). T4SS is conserved in all <italic>Brucella</italic> species and its expression is regulated by environmental signals, such as low pH, high temperature, and interaction with host cells (<xref rid="bib60" ref-type="bibr">Ke, Wang, Li, &amp; Chen, 2015</xref>; <xref rid="bib114" ref-type="bibr">Sieira, Comerci, S&#xE1;nchez, &amp; Ugalde, 2000</xref>). The secretion apparatus of <italic>Brucella</italic>'s T4SS is comprised of three main components: the core components (VirB3, VirB4, VirB6-10), the external pilus (VirB2 and VirB5), and energy-providing ATPases (VirB4, VirB11), which form a translocation channel allowing effector proteins to be delivered into host cells. While a significant number of <italic>Brucella</italic> effector proteins have been identified and studied, the exact count of effector proteins remains to be fully determined. Currently, 15 effector proteins have been identified to manipulate host cellular processes and immune responses, including RicA, VceC, VecA, BtpA, BtpB, BspA, and BspB (<xref rid="bib61" ref-type="bibr">Lacerda, Salcedo, &amp; Gorvel, 2013</xref>; <xref rid="bib61" ref-type="bibr">Lacerda et&#xA0;al., 2013</xref>; <xref rid="bib138" ref-type="bibr">Xiong et&#xA0;al., 2021</xref>). Ongoing research aiming to discover and characterize additional effector proteins to enhance our understanding of host-pathogen interactions is crucial for therapy and vaccines development targeting <italic>Brucella</italic>.</p>
      <p id="p0020">The immune system comprises innate immunity and adaptive immunity (<xref rid="bib67" ref-type="bibr">Li, 2022</xref>; <xref rid="bib153" ref-type="bibr">Zhong, Tien, &amp; Shu, 2006</xref>). Innate immunity serves as the initial defense against pathogen intrusion and relies on the recognition of pathogen-associated molecular patterns (PAMPs) by host pattern recognition receptors (PRRs) to trigger the production of interferons (IFNs) and inflammatory cytokines that eliminate pathogens from the host (<xref rid="bib52" ref-type="bibr">Hu &amp; Shu, 2018</xref>; <xref rid="bib137" ref-type="bibr">Xia, Yi, Wu, Shang, &amp; Shu, 2019</xref>; <xref rid="bib142" ref-type="bibr">Yi, Lian, &amp; Li, 2022</xref>; <xref rid="bib153" ref-type="bibr">Zhong et&#xA0;al., 2006</xref>). Adaptive immunity serves as a secondary defense mechanism to innate immunity by activating antigen-presenting cells such as dendritic cells, phagocytes, cytotoxic lymphocytes, and promoting the production of antibodies (<xref rid="bib3" ref-type="bibr">An et&#xA0;al., 2022</xref>; <xref rid="bib67" ref-type="bibr">Li, 2022</xref>; <xref rid="bib100" ref-type="bibr">Ruf, Greten, &amp; Korangy, 2023</xref>; <xref rid="bib109" ref-type="bibr">Shao, Liu, &amp; Qi, 2023</xref>). During prolonged interactions with the host, <italic>Brucella</italic> undergoes evolutionary adaptations and primarily employs &#x201C;stealth&#x201D; strategies to evade, interfere with, or suppress immune responses, leading to the establishment of chronic and persistent infection (<xref rid="bib16" ref-type="bibr">Cardoso, Macedo, Azevedo, &amp; Oliveira, 2006</xref>; <xref rid="bib61" ref-type="bibr">Lacerda et&#xA0;al., 2013</xref>; <xref rid="bib63" ref-type="bibr">Lapaque, Muller, Alexopoulou, Howard, &amp; Gorvel, 2009</xref>). This review summarizes the recently discovered mechanisms employed by <italic>Brucella</italic> to subvert host immune responses and cellular homeostasis, as well as reveals research progress on vaccines with the aim of advancing our understanding of brucellosis and facilitating the development of more effective vaccines and therapeutic approaches against <italic>Brucella</italic>.</p>
      <sec id="sec1.1">
        <label>1.1</label>
        <title>The cellular niche of <italic>Brucella</italic></title>
        <p id="p0025"><italic>Brucella</italic> has a strong ability to persist and reproduce within macrophages, dendritic cells, and placental trophoblast cells (<xref rid="bib22" ref-type="bibr">Copin et&#xA0;al., 2012</xref>). <italic>Brucella</italic> infection can be divided into three stages: invasion, acute infection, and chronic infection. At the beginning of the infection, host cells activate innate immunity to suppress <italic>Brucella</italic> replication, while adaptive immunity takes over during the later stages (<xref rid="bib7" ref-type="bibr">Baldwin &amp; Goenka, 2006</xref>). Nevertheless, <italic>Brucella</italic> employs various strategies to evade the host's immune system, allowing for colonization, growth, and prolonged multiplication. The chronic infection occurs due to the balanced interaction between <italic>Brucella</italic> and the host to maintain over a long period of time (<xref rid="bib42" ref-type="bibr">Grill&#xF3;, Blasco, Gorvel, Moriy&#xF3;n, &amp; Moreno, 2012</xref>).</p>
        <p id="p0030">To establish infection, <italic>Brucella</italic> initially interacts with host cell membranes through lipid rafts, facilitating its intracellular vesicular transport by forming a specialized compartment called the <italic>Brucella</italic>-containing vacuole (BCV). The BCV temporarily associates with endosomes forming an early endosomal <italic>Brucella</italic>-containing vacuole (eBCV). During transportation, eBCVs lose early endosomal markers, and most of them are cleared by lysosomes but a small number of eBCVs evade lysosomal clearance. Studies suggest that the fusion of eBCV with lysosomes can promote its maturation and connection with the endoplasmic reticulum (ER) (<xref rid="bib118" ref-type="bibr">Starr, Ng, Wehrly, Knodler, &amp; Celli, 2008</xref>). At this stage, the eBCV transforms into a mature replicating <italic>Brucella</italic>-containing vacuole (rBCV). The ER provides an optimal environment for <italic>Brucella</italic> to replicate and enhance its pathogenicity (<xref rid="bib106" ref-type="bibr">Sedzicki et&#xA0;al., 2018</xref>). Current studies suggest that eBCV can merge with the ER via COP II vesicles and activate Sar1 protein during vesicle transport (<xref rid="bib17" ref-type="bibr">Celli, 2019</xref>; <xref rid="bib57" ref-type="bibr">Jiao et al., 2021</xref>). Additionally, the fusion of eBCV with the ER is dependent on the small GTPase Rab2 (<xref rid="bib38" ref-type="bibr">Fugier et&#xA0;al., 2009</xref>). Yip1A phosphorylates IRE1&#x3B1; at the ERES, leading to the activation of IRE1&#x3B1;. This activation stimulates the production of ER-derived vesicles that merge with eBCV, resulting in the formation of rBCV, and this continuous fusion process with secreted ER vesicles facilitates <italic>Brucella</italic> proliferation (<xref rid="bib119" ref-type="bibr">Taguchi et&#xA0;al., 2015</xref>). Whereas the precise molecular mechanisms mediating the fusion of eBCV with the ER have yet to be fully elucidated and require further investigation. In later stages of infection, rBCV transforms into autophagic <italic>Brucella</italic>-containing vacuoles (aBCV), which differ from traditional autophagosomes. Intriguingly, the formation of aBCV requires autophagy initiation factors like ULK1, Beclin1, ATG14L, and PI3K kinase, but it does not involve autophagy extension factors such as ATG5, ATG16L1, ATG4B, ATG7, and LC3 (<xref rid="bib57" ref-type="bibr">Jiao et al., 2021</xref>; <xref rid="bib117" ref-type="bibr">Starr et&#xA0;al., 2012</xref>). Eventually, <italic>Brucella</italic> completes its intracellular cycle and is released through lytic and non-lytic mechanisms, allowing for a new round of infection (<xref rid="fig1" ref-type="fig">Fig.&#xA0;1</xref>).<fig id="fig1"><label>Fig.&#xA0;1</label><caption><p><bold>The replication cycle of <italic>Brucella</italic> and potential mechanisms to evade innate immunity.</bold><italic>Brucella</italic> binds to the host cell membrane using lipid rafts and utilizes intracellular vesicles for transportation. Once inside the host cell, it forms a vesicle called the <italic>Brucella</italic>-containing vacuole (BCV). The BCV then acquires certain host marker molecules (EEA1 and Rab5), which transforms it into an early BCV (eBCV). The eBCV interacts with lysosomes, acquiring additional host marker proteins (Rab7 and LAMP-1) to facilitate the fusion between the eBCV and lysosomes, allowing <italic>Brucella</italic> to evade the damaging effects of lysosomes. Through T4SS, an effector protein interacts with the exit site of the ER, enabling the eBCV transition to the ER, where it acquires marker molecules (Rab2 and Sar1), resulting in the formation of rBCV. The ER provides an optimal environment for <italic>Brucella</italic> replication. Ultimately, <italic>Brucella</italic> establishes colonization within the ER, undergoes proliferation, and is eventually released, initiating a new round of pathogenic infection. Several effector proteins secreted by <italic>Brucella</italic>'s T4SS are crucial for suppressing the host immune response. BtpA competitively binds to TIRAP/MAL, which prevents TIRAP/MAL from interacting with MyD88 and inhibits the NF-&#x3BA;B signaling pathway activated by TLR4, enabling <italic>Brucella</italic> to evade the innate immune response. <italic>Brucella</italic> VceC is involved in endoplasmic reticulum stress. The arrowhead represents the directional translocation of vesicles and signal transduction.</p></caption><alt-text id="alttext0010">Fig.&#xA0;1</alt-text><graphic xlink:href="gr1"/></fig></p>
        <p id="p0035">Under acidic pH conditions, the <italic>Brucella</italic> type IV secretion system can be triggered to release various effector proteins, which aid <italic>Brucella</italic> in evading host defense responses and suppressing the host immune responses (<xref rid="bib11" ref-type="bibr">Boschiroli et&#xA0;al., 2002</xref>). In recent years, various studies have revealed that <italic>Brucella</italic>, as well as other intracellular parasitic pathogens like Chlamydia, employ different strategies to exploit the vesicular transport pathway of host cells (<xref rid="bib9" ref-type="bibr">Bestebroer, V'kovski, Mauthe, &amp; Reggiori, 2013</xref>; <xref rid="bib19" ref-type="bibr">Chen, Zhao, &amp; Zhang, 2022</xref>). These findings suggest the potential for developing vaccines that can stimulate immune responses to interfere with the initial stages of infection, including neutralizing the virulence factors released by <italic>Brucella</italic> to inhibit its replication within host cells.</p>
      </sec>
      <sec id="sec1.2">
        <label>1.2</label>
        <title><italic>Brucella</italic> undermines innate immunity</title>
        <p id="p0040">The innate immune response serves as the initial defense against pathogens infection, playing a crucial role in inhibiting and eliminating invading pathogens (<xref rid="bib135" ref-type="bibr">Wu et&#xA0;al., 2019</xref>). This defense involves the coordinated actions of immune cells like macrophages, immune molecules like PRRs and PAMPs, and complement systems (<xref rid="bib83" ref-type="bibr">Martirosyan, Moreno, &amp; Gorvel, 2011</xref>). PRRs comprise multiple components, including Toll-like receptors (TLRs) located on the cell membrane, intracellular Nod-like receptors (NLRs), RNA or DNA sensors and the complement system (<xref rid="bib148" ref-type="bibr">Zhang &amp; Zhong, 2022</xref>). These receptors recognize PAMPs and initiate appropriate immune responses to restrain pathogens infection to enhance host defense responses (<xref rid="bib83" ref-type="bibr">Martirosyan et&#xA0;al., 2011</xref>; <xref rid="bib113" ref-type="bibr">Shu, Takeuchi, &amp; Goeddel, 1996</xref>; <xref rid="bib136" ref-type="bibr">Wu et&#xA0;al., 2022</xref>; <xref rid="bib139" ref-type="bibr">Xu et&#xA0;al., 2005</xref>; <xref rid="bib150" ref-type="bibr">Zheng et&#xA0;al., 2022</xref>; <xref rid="bib154" ref-type="bibr">Zhong et&#xA0;al., 2008</xref>). On the other hand, <italic>Brucella</italic> employs &#x201C;stealth&#x201D; strategies to evade host immune responses, specifically by evading continuous recognition by PRRs and suppressing immune responses. These strategies allow <italic>Brucella</italic> to effectively evade and subvert host immune defenses (<xref rid="bib83" ref-type="bibr">Martirosyan et&#xA0;al., 2011</xref>).</p>
      </sec>
      <sec id="sec1.3">
        <label>1.3</label>
        <title><italic>Brucella</italic> evades PRRs recognition</title>
        <p id="p0045">During <italic>Brucella</italic> infection, innate immune responses are not effectively triggered due to unique structural characteristics of <italic>Brucella</italic> which can prevent the activation of PRRs and the complement system. TLRs are crucial regulators of innate immune signaling and facilitate communications between adaptive and innate immunity, allowing the immune system to mount strong responses against various pathogens (<xref rid="bib141" ref-type="bibr">Yang et&#xA0;al., 2017</xref>; <xref rid="bib152" ref-type="bibr">Zhong et&#xA0;al., 2020</xref>). The molecular components on the surface of <italic>Brucella</italic>, such as lipopolysaccharides (LPS), lipoproteins, and flagella, do not effectively stimulate the innate immune system by evading PRRs recognition (<xref rid="bib40" ref-type="bibr">Gorvel, 2008</xref>). The lipid A of <italic>Brucella</italic> LPS has longer fatty acid chains (C28), which reduces its recognition by TLR4 and suppresses the activation of inflammatory response (<xref rid="bib64" ref-type="bibr">Lapaque et&#xA0;al., 2006</xref>). However, the flagellin produced by <italic>Brucella</italic> lacks the specific structural domain that activates TLR5, further contributing to its ability to evade immune detection (<xref rid="bib2" ref-type="bibr">Andersen-Nissen et&#xA0;al., 2005</xref>; <xref rid="bib47" ref-type="bibr">Hoebe, Janssen, &amp; Beutler, 2004</xref>) (<xref rid="fig1" ref-type="fig">Fig.&#xA0;1</xref>). To successfully replicate, <italic>Brucella</italic> has developed the T4SS which secretes effector proteins to manipulate immune signaling, facilitating adhesion, internalization, intracellular transport, and replication within host cells (<xref rid="bib60" ref-type="bibr">Ke et&#xA0;al., 2015</xref>; <xref rid="bib138" ref-type="bibr">Xiong et&#xA0;al., 2021</xref>). Notably, BtpA and BtpB, important virulence factors, possess conserved Toll/Interleukin 1 receptor (TIR) structural domains. These domains can regulate innate immune responses by inhibiting the activation of the TLR signaling pathway (<xref rid="bib61" ref-type="bibr">Lacerda et&#xA0;al., 2013</xref>). The TIR domain containing adapter protein (TIRAP/MAL) mediates TLR signaling pathway through interaction with MyD88 (<xref rid="bib69" ref-type="bibr">Li et&#xA0;al., 2016</xref>; <xref rid="bib91" ref-type="bibr">O'Neill et&#xA0;al., 2003</xref>). BtpA competitively binds to MyD88 and promotes the degradation of phosphorylated TIRAP/MAL by enhancing its polyubiquitination, effectively blocking TIRAP/MAL-induced NF-&#x3BA;B activation (<xref rid="bib108" ref-type="bibr">Sengupta et&#xA0;al., 2010</xref>; <xref rid="bib116" ref-type="bibr">Snyder et&#xA0;al., 2014</xref>). On the other hand, BtpB exhibits an even stronger inhibition of TLR2, TLR4, and TLR9 signaling compared to BtpA. BtpB also interacts with MyD88 and prevents NF-&#x3BA;B translocating to the nucleus (<xref rid="bib98" ref-type="bibr">radhakrishnan &amp; Splitter, 2010</xref>; <xref rid="bib102" ref-type="bibr">Salcedo et&#xA0;al., 2013</xref>; <xref rid="bib105" ref-type="bibr">Saqib &amp; Baig, 2019</xref>). Recently, studies have shown that NLRs, as intracellular PRRs, can also recognize intracellular <italic>Brucella</italic> (<xref rid="bib119" ref-type="bibr">Taguchi et&#xA0;al., 2015</xref>).</p>
      </sec>
      <sec id="sec1.4">
        <label>1.4</label>
        <title><italic>Brucella</italic> evades the inflammatory signaling</title>
        <p id="p0050">The inflammatory responses serve as crucial defense mechanisms for eliminating pathogens infection and initiating the healing process (<xref rid="bib51" ref-type="bibr">Hsu, Shu, Pan, &amp; Goeddel, 1996</xref>; <xref rid="bib65" ref-type="bibr">Lei et&#xA0;al., 2019</xref>). Multiple outer membrane proteins (Omps) regulate inflammatory responses and promote self-replication. Notably, Omp25 and Omp31 are significant Omps associated with <italic>Brucella</italic>'s virulence, with the deletion of Omp25 shown to decrease virulence and promote the production of inflammatory factors in murine models (<xref rid="bib140" ref-type="bibr">Yang et&#xA0;al., 2020</xref>). Omp25 has been found to upregulate microRNAs associated with TNF-&#x3B1;, inhibiting TNF-&#x3B1; production and suppressing the release of inflammatory factors mediated by the NF-&#x3BA;B pathway (<xref rid="bib79" ref-type="bibr">Luo et&#xA0;al., 2017</xref>). Additionally, Omp25 can modulate the <italic>Brucella</italic>-activated MAPK pathway, further suppressing TNF-&#x3B1; expression (<xref rid="bib147" ref-type="bibr">ZHANG, ZHANG, et&#xA0;al., 2017</xref>). Omp31 plays a critical role in maintaining the integrity of <italic>Brucella</italic>'s outer membrane, which is essential for bacterial invasion, establishment, and the formation of replicative ecological niches (<xref rid="bib6" ref-type="bibr">BAI et&#xA0;al., 2021</xref>). Omp31-induced autophagy negatively regulates the NF-&#x3BA;B p65 signaling pathway, leading to the inhibition of TNF-&#x3B1; expression (<xref rid="bib131" ref-type="bibr">Wang et&#xA0;al., 2021</xref>).</p>
      </sec>
      <sec id="sec1.5">
        <label>1.5</label>
        <title><italic>Brucella</italic> evades the complement system</title>
        <p id="p0055">The complement system is a diverse group of proteins that can effectively kill most Gram-negative bacteria by binding to C3 and initiating complement system-mediated clearance (<xref rid="bib48" ref-type="bibr">Hoffmann &amp; Houle, 1995</xref>). The O-antigen of <italic>Brucella</italic> is distinct from that of <italic>Salmonella typhimurium</italic>. Specifically, the O-antigen of <italic>Brucella</italic> lacks free OH-groups and is linked to 4,6-dideoxy-4-formamido-alpha-d mannopyranosyl residues, enabling <italic>Brucella</italic> to hinder the production of C3a and C5a upon interaction with C3, thereby modulating the host immune response. Furthermore, <italic>Brucella</italic>'s surface lipopolysaccharide (LPS) has long polysaccharide side chains that make it difficult for the complement factors to bind to the bacteria's cell membrane. As a result, <italic>Brucella</italic> can escape recognition and destruction by the complement system (<xref rid="bib8" ref-type="bibr">Barquero-Calvo et&#xA0;al., 2007</xref>).</p>
        <p id="p0060">These studies suggest that <italic>Brucella</italic> employs specific strategies including modulating phagocytic activity, inhibiting PRRs like TLRs and NLRs, suppressing inflammatory responses, and interfering with the complement system to regulate and evade the innate immune responses (<xref rid="tbl1" ref-type="table">Table&#xA0;1</xref>). Furthermore, the <xref rid="tbl1" ref-type="table">Table&#xA0;1</xref> also provides a summary of <italic>Brucella</italic> virulence factors involved in the interaction between <italic>Brucella</italic> and the host's innate immunity.<table-wrap position="float" id="tbl1"><label>Table&#xA0;1</label><caption><p><italic>Brucella</italic> encoded proteins involved in evading host innate immunity.</p></caption><alt-text id="alttext0020">Table&#xA0;1</alt-text><table frame="hsides" rules="groups"><thead><tr><th>Name</th><th>Gene</th><th>Type</th><th>Function</th><th>Seleted references</th></tr></thead><tbody><tr><td rowspan="2" align="left">Omp19</td><td rowspan="2" align="left">BS1330_I1924</td><td rowspan="2" align="left">Omps</td><td align="left">Inhibit MHC-&#x2161; expression and antigen processing by interacting with TLR2.</td><td align="left"><xref rid="bib30" ref-type="bibr">Delpino et&#xA0;al., 2012</xref>; <xref rid="bib37" ref-type="bibr">Ferrero et&#xA0;al., 2014</xref></td></tr><tr><td align="left">Evade the proteolytic defense system.</td><td align="left"><xref rid="bib96" ref-type="bibr">Pasquevich et al., 2019</xref></td></tr><tr><td align="left">Omp22</td><td align="left">Bsuis_A1680</td><td align="left">Omps</td><td align="left">Inhibit the expression of inflammatory cytokines.</td><td align="left"><xref rid="bib139" ref-type="bibr">Xu et al., 2005</xref></td></tr><tr><td rowspan="4" align="left">Omp25</td><td rowspan="4" align="left">BS1330_I0697</td><td rowspan="4" align="left">Omps</td><td align="left">Inhibit the NF-&#x3BA;B signaling pathway and production of inflammatory cytokines.</td><td align="left"><xref rid="bib29" ref-type="bibr">Degos et al., 2020</xref></td></tr><tr><td align="left">Degrade cGAS by ubiquitin proteasome pathway and inhibit IFN-&#x3B2; production.</td><td align="left"><xref rid="bib70" ref-type="bibr">Li et al., 2021</xref></td></tr><tr><td align="left">Regulate miRNA to inhibit TNF-&#x3B1; production.</td><td align="left"><xref rid="bib25" ref-type="bibr">Cui et al., 2017</xref></td></tr><tr><td align="left">Inhibit the maturation of DCs and reduce the activity of antigen presentation.</td><td align="left"><xref rid="bib147" ref-type="bibr">Zhang et al., 2017b</xref></td></tr><tr><td align="left">Omp31</td><td align="left">BRA0423</td><td align="left">Omps</td><td align="left">Inhibit NF-&#x3BA;B p65 signal pathway and TNF-&#x3B1; expression.</td><td align="left"><xref rid="bib131" ref-type="bibr">Wang et&#xA0;al., 2021</xref>; <xref rid="bib145" ref-type="bibr">Zhang et&#xA0;al., 2016</xref></td></tr><tr><td rowspan="4" align="left">TcpB/BtpA</td><td rowspan="4" align="left">BAB1_0279</td><td rowspan="4" align="left">Secretory</td><td align="left">Inhibit the NF-&#x3BA;B signaling pathway mediated by TLR4 and TLR2 and the maturation of DCs.</td><td align="left"><xref rid="bib103" ref-type="bibr">Salcedo et&#xA0;al., 2008</xref>; <xref rid="bib105" ref-type="bibr">Saqib &amp; Baig, 2019</xref></td></tr><tr><td align="left">Combine with MyD88 and degrade MAL.</td><td align="left"><xref rid="bib108" ref-type="bibr">Sengupta et al., 2010</xref></td></tr><tr><td align="left">Inhibit CD8<sup>+</sup>T cells from killing infected bacterial cells.</td><td align="left"><xref rid="bib32" ref-type="bibr">Durward et al., 2012</xref></td></tr><tr><td align="left">Inhibit the activation of inflammasome.</td><td align="left"><xref rid="bib55" ref-type="bibr">Jakka et al., 2017</xref></td></tr><tr><td rowspan="2" align="left">BtpB</td><td rowspan="2" align="left">BAB1_0756</td><td rowspan="2" align="left">Secretory</td><td align="left">Inhibit of signal transduction of TLR2 and TLR4 and inflammatory.</td><td rowspan="2" align="left"><xref rid="bib102" ref-type="bibr">Salcedo et al., 2013</xref></td></tr><tr><td align="left">Interaction with MyD88 and regulation of NF-&#x3BA;B translocation to the nucleus.</td></tr><tr><td align="left">BspB</td><td align="left">BAB1_0712</td><td align="left">Secretory</td><td align="left">Competitive binding of IRF3, inhibition of phosphorylation and nucleation of IRF3, and inhibition of IFN-&#x3B2; production.</td><td align="left"><xref rid="bib68" ref-type="bibr">Li, 2023</xref></td></tr><tr><td align="left">RicA</td><td align="left">BMEI_0736</td><td align="left">Secretory</td><td align="left">Degrade STING by the autophagosome pathway and inhibit IFN-&#x3B2; production.</td><td align="left"><xref rid="bib68" ref-type="bibr">Li, 2023</xref></td></tr><tr><td rowspan="2" align="left">VceC</td><td rowspan="2" align="left">BAB1_1058</td><td rowspan="2" align="left">Secretory</td><td align="left">Activate NF-&#x3BA;B signaling pathway and participate in inflammatory reaction.</td><td align="left"><xref rid="bib28" ref-type="bibr">De Jong et al., 2013</xref></td></tr><tr><td align="left">Induce unfolded protein reaction to recombine the structure of ER.</td><td align="left"><xref rid="bib28" ref-type="bibr">De Jong et&#xA0;al., 2013</xref>; <xref rid="bib151" ref-type="bibr">Zhi et al., 2019</xref></td></tr><tr><td align="left"><italic>c</italic>-di-GMP</td><td/><td align="left">Second messenger</td><td align="left">Interact with STING, and initiate IFN-I immune response via TBK1-IRF3 signaling pathway.</td><td align="left"><xref rid="bib24" ref-type="bibr">Costa Franco et al., 2018</xref><break/><xref rid="bib99" ref-type="bibr">Roop et al., 2021</xref></td></tr><tr><td rowspan="2" align="left">LPS</td><td rowspan="2"/><td rowspan="2" align="left">Lipopolysaccharide</td><td align="left">Evade TLR4 identification.</td><td align="left"><xref rid="bib64" ref-type="bibr">Lapaque et al., 2006</xref></td></tr><tr><td align="left">Inhibit the activation of the complement system.</td><td align="left"><xref rid="bib8" ref-type="bibr">Barquero-Calvo et al., 2007</xref></td></tr><tr><td align="left">Flagellin</td><td/><td/><td align="left">Evade TLR5 identification.</td><td align="left"><xref rid="bib2" ref-type="bibr">Andersen-Nissen et al., 2005</xref></td></tr></tbody></table></table-wrap></p>
      </sec>
      <sec id="sec1.6">
        <label>1.6</label>
        <title><italic>Brucella</italic> undermines adaptive immunity</title>
        <p id="p0065">Adaptive immunity is a defense mechanism in the immune system that develops long-term immunity against infections (<xref rid="bib21" ref-type="bibr">Cooper &amp; Alder, 2006</xref>; <xref rid="bib90" ref-type="bibr">Netea, Schlitzer, Placek, Joosten, &amp; Schultze, 2019</xref>). When <italic>Brucella</italic> infection occurs, three primary mechanisms activate the adaptive immune response (<xref rid="bib82" ref-type="bibr">Martirosyan &amp; Gorvel, 2013</xref>). Firstly, CD4<sup>+</sup>/CD8<sup>+</sup> T cells produce IFN-&#x3B3;, activating macrophages to prevent <italic>Brucella</italic> from replicating inside host cells. A second mechanism involves CD8<sup>+</sup> T cells, which have a cytotoxic effect that eliminates infected macrophages. Additionally, the third mechanism involves Th1 antibody subtypes like IgG2a/IgG3, which enhance the phagocytosis of degraded BCVs (<xref rid="bib42" ref-type="bibr">Grill&#xF3; et&#xA0;al., 2012</xref>; <xref rid="bib82" ref-type="bibr">Martirosyan &amp; Gorvel, 2013</xref>). Antigen-presenting cells (APCs) recognize <italic>Brucella</italic> antigens and secrete IL-12 cytokines. These cytokines activate CD4<sup>+</sup> and CD8<sup>+</sup> T cells, as well as Th1 and Th2 helper T cells. In turn, these cells secrete cytokines like TNF&#x3B1;, IL-2, IL-4, IL-10, and IFN-&#x3B3;, which help regulate the adaptive immune response and aid in the clearance of <italic>Brucella</italic> by macrophages (<xref rid="fig2" ref-type="fig">Fig.&#xA0;2</xref>) (<xref rid="bib35" ref-type="bibr">Elrashedy et al</xref>.; <xref rid="bib1" ref-type="bibr">Ali et&#xA0;al., 2023</xref>; <xref rid="bib83" ref-type="bibr">Martirosyan et&#xA0;al., 2011</xref>)<italic>.</italic> To establish a persistent infection in the host, <italic>Brucella</italic> steadily exerts immunosuppressive effects on the adaptive immune response. In mice infected with <italic>Brucella</italic> abortus, there is an increased population of CD4<sup>+</sup> and CD25<sup>+</sup> T cells in the spleen which play a regulatory role in the persistence of the infection (<xref rid="bib95" ref-type="bibr">Pasquali et&#xA0;al., 2010</xref>). <italic>Brucella</italic> has developed mechanisms to hinder the transition from innate to adaptive immune signaling by manipulating DCs, thereby evading host immunity (<xref rid="bib31" ref-type="bibr">Dudek, Martin, Garg, &amp; Agostinis, 2013</xref>). <italic>Brucella</italic> Omp19 and Omp25 have been shown to reduce the secretion of cytokines TNF-&#x3B1; and IL-12, which subsequently impairs the activation of T-cells by DCs. This hindrance in initiating the host's protective Th1 immune responses gives <italic>Brucella</italic> an advantage in effectively concealing their presence (<xref rid="bib5" ref-type="bibr">Avila-Calder&#xF3;n et&#xA0;al., 2020</xref>; <xref rid="bib10" ref-type="bibr">Billard, Dornand, &amp; Gross, 2007</xref>; <xref rid="bib83" ref-type="bibr">Martirosyan et&#xA0;al., 2011</xref>; <xref rid="bib103" ref-type="bibr">Salcedo et&#xA0;al., 2008</xref>). <italic>Brucella</italic> LPS can evade host adaptive immune clearance by impairing the recognition and presentation of antigens by MHC II molecules in APCs and inhibiting antibody production by B cells (<xref rid="bib64" ref-type="bibr">Lapaque et&#xA0;al., 2006</xref>). Recent studies have also found that BtpA, a novel effector involved in evading the adaptive immune response, interacts with phosphatidylinositol-4,5-bisphosphate (PI (4,5) P2) or PI (3,4,5) P3. This interaction inhibits the activation of APCs at the immune synapse, impairing the cytotoxicity of CD8<sup>+</sup> T cells (<xref rid="bib32" ref-type="bibr">Durward et&#xA0;al., 2012</xref>).<fig id="fig2"><label>Fig.&#xA0;2</label><caption><p><bold><italic>Brucella</italic> modulates adaptive immune responses.</bold> Recognition of <italic>Brucella</italic> antigens by antigen-presenting cells (APCs) leads to the production of IL-12 cytokines. These cytokines activate CD4<sup>+</sup> T cells and Th2 helper T cells, which secrete cytokines like IL-4 and IL-10. These cytokines further stimulate B lymphocytes, enhancing their involvement in humoral immunity and facilitating the rapid elimination of pathogens from the host. Additionally, APCs can activate Th1 helper T cells, promote the maturation of CD8<sup>+</sup> T cells, and participate in cytotoxic T cell (CTL) activity. This CTL activity specifically targets and destroys <italic>Brucella</italic>-infected cells, while also releasing various cytokines such as TNF-&#x3B1;, IL-2, and IFN-&#x3B3;. These cytokines play a role in promoting the immune clearance of <italic>Brucella</italic> by macrophages.</p></caption><alt-text id="alttext0015">Fig.&#xA0;2</alt-text><graphic xlink:href="gr2"/></fig></p>
        <p id="p0070">In summary, the inadequate immune responses seen in <italic>Brucella</italic> infection can be attributed to both the inhibition of innate immune responses and adaptive immune responses, which struggle to fully eradicate the infection. Improving our understanding of the interaction between <italic>Brucella</italic> and the host's immune system could provide valuable insights into <italic>Brucella</italic>'s pathogenesis and aid in the development of effective vaccines and therapies.</p>
      </sec>
      <sec id="sec1.7">
        <label>1.7</label>
        <title><italic>Brucella</italic> regulates cellular homeostasis</title>
        <p id="p0075">Cellular homeostasis is vital for maintaining cell functions, including stability, metabolism, and response to environmental stresses. Loss of control over cellular homeostasis can lead to diseases like cancer, inflammation, and immune system disorders (<xref rid="bib85" ref-type="bibr">Meizlish, Franklin, Zhou, &amp; Medzhitov, 2021</xref>; <xref rid="bib133" ref-type="bibr">Wei, Zheng, Chapman, Geiger, &amp; Chi, 2021</xref>; <xref rid="bib134" ref-type="bibr">Wong et&#xA0;al., 2021</xref>; <xref rid="bib143" ref-type="bibr">Yin, Chen, &amp; Eisenbarth, 2021</xref>; <xref rid="bib149" ref-type="bibr">Zhang et&#xA0;al., 2021</xref>). The endoplasmic reticulum (ER) serves as the calcium reservoir and is responsible for processing, folding, and transporting proteins, crucial for maintaining cellular homeostasis (<xref rid="bib80" ref-type="bibr">Marchi et&#xA0;al., 2018</xref>). <italic>Brucella</italic> invades the cell and proliferates within the ER, disrupting its homeostasis and inducing prolonged and excessive endoplasmic reticulum stress (ER Stress). This disruption fails to restore cellular homeostasis, ultimately causing cell death (<xref rid="bib15" ref-type="bibr">Byndloss et&#xA0;al., 2019</xref>; <xref rid="bib128" ref-type="bibr">Wang et&#xA0;al., 2015</xref>, <xref rid="bib127" ref-type="bibr">2016</xref>). Furthermore, <italic>Brucella</italic> can evade the host elimination by inhibiting cell death and utilize the host autophagy process.</p>
      </sec>
      <sec id="sec1.8">
        <label>1.8</label>
        <title><italic>Brucella</italic> regulates apoptosis</title>
        <p id="p0080">Apoptosis is a regulatory mechanism responsible for programmed cell death and defending against intracellular bacteria, mainly triggered by caspases (<xref rid="bib12" ref-type="bibr">Bronner, O'Riordan, &amp; He, 2013</xref>). <italic>Brucella</italic> evades the immune response by inhibiting apoptosis, enabling the bacteria to replicate within infected cells. This is partially achieved by increasing the expression of zinc finger protein A20, which inhibits the NF-&#x3BA;B pathway. As a result, Caspase-8 activation caused macrophage apoptosis is restricted to create a favorable environment for bacterial proliferation (<xref rid="bib132" ref-type="bibr">Wei et&#xA0;al., 2015</xref>). Additionally, <italic>B.&#xA0;melitensis</italic> infection has been found to reduce the expression of genes involved in the mitochondrial apoptotic pathway. <italic>Brucella</italic> VceC regulates IRE1 pathway and inhibits CHOP-induced apoptosis to support replication in goat trophoblast cells (<xref rid="bib151" ref-type="bibr">Zhi et al., 2019</xref>). These findings collectively indicate that <italic>Brucella</italic> employs apoptosis inhibition as a strategy to evade the host immune response and promote intracellular replication.</p>
      </sec>
      <sec id="sec1.9">
        <label>1.9</label>
        <title><italic>Brucella</italic> regulates pyroptosis</title>
        <p id="p0085">Pyroptosis, also known as cellular inflammatory necrosis, is an important immune response against pathogens. It is triggered by the activation of caspase-1 and leads to the release of pro-inflammatory cytokines like IL-1&#x3B2; and IL-18 to help recruit and activate immune cells to control infections (<xref rid="bib50" ref-type="bibr">Hsu et&#xA0;al., 2021</xref>). Key mediators such as Caspase-1, Gasdermin D (GSDMD), IL-1&#x3B2;, IL-18, NLRP3, AIM2, and others play a crucial role in protecting against bacterial infections (<xref rid="bib59" ref-type="bibr">Karmakar et&#xA0;al., 2020</xref>; <xref rid="bib81" ref-type="bibr">Marim et&#xA0;al., 2017</xref>; <xref rid="bib110" ref-type="bibr">Shi et&#xA0;al., 2021</xref>). Extensive research has shown that pyroptosis acts as a defense mechanism against <italic>Brucella</italic> infections (<xref rid="bib23" ref-type="bibr">Costa Franco et&#xA0;al., 2019</xref>; <xref rid="bib62" ref-type="bibr">Lacey, Mitchell, Dadelahi, &amp; Skyberg, 2018</xref>; <xref rid="bib122" ref-type="bibr">Tupik et&#xA0;al., 2020</xref>). To persist within host cells, <italic>Brucella</italic> employs various strategies to inhibit pyroptosis. Recent studies have revealed that the T4SS plays a critical role in triggering the formation of inflammatory vesicles in infected macrophages (<xref rid="bib81" ref-type="bibr">Marim et&#xA0;al., 2017</xref>). The secreted protein TcpB, derived from <italic>Brucella</italic>-infected macrophages, inhibits the activation of nonclassical inflammatory vesicles induced by LPS. Moreover, TcpB induces ubiquitination and subsequent degradation of caspase-1, caspase-4, and caspase-11, effectively blocking pyroptosis (<xref rid="bib55" ref-type="bibr">Jakka, Namani, Murugan, Rai, &amp; Radhakrishnan, 2017</xref>). These findings indicate that <italic>Brucella</italic> actively interferes with cell death. Importantly, further investigation is needed to fully understand the underlying mechanism.</p>
      </sec>
      <sec id="sec1.10">
        <label>1.10</label>
        <title><italic>Brucella</italic> regulates autophagy</title>
        <p id="p0090">Autophagy is a significant defense process employed by the host to remove intracellular pathogens. Some bacteria have the ability to manipulate autophagy, which helps them survive and evade host clearance (<xref rid="bib73" ref-type="bibr">Liu &amp; Levine, 2015</xref>). Studies have demonstrated that autophagy-associated proteins play a vital role in the formation of rBCV, aiding <italic>Brucella</italic> in completing its intracellular life cycle (<xref rid="bib117" ref-type="bibr">Starr et&#xA0;al., 2012</xref>). By activating IRE1&#x3B1; through Yip1A, <italic>Brucella</italic> upregulates the expression of Sar1 and COPII, leading to vacuole formation in the endoplasmic reticulum. This conversion of BCV to rBCV promotes <italic>Brucella</italic>'s survival (<xref rid="bib119" ref-type="bibr">Taguchi et&#xA0;al., 2015</xref>; <xref rid="bib130" ref-type="bibr">Wang et&#xA0;al., 2014</xref>). These findings highlight how <italic>Brucella</italic> manipulates autophagy as a strategy to counteract host immune responses. Identifying and targeting <italic>Brucella</italic> effectors or host molecular switches involved in regulating defense responses could provide a novel approach to controlling <italic>Brucella</italic> infections.</p>
      </sec>
      <sec id="sec1.11">
        <label>1.11</label>
        <title><italic>Brucella</italic> vaccines</title>
        <p id="p0095">Vaccination is one of the most effective strategies in controlling <italic>Brucella</italic> infection. However, there is currently no globally recognized vaccine against <italic>Brucella</italic> for human use (<xref rid="bib56" ref-type="bibr">Jiang, O'callaghan, &amp; Ding, 2020</xref>). Moreover, there is few information and relevant data regarding clinical trials of <italic>Brucella</italic> vaccines in human subjects. The key challenge in developing <italic>Brucella</italic> vaccine for human use are safety issues, which must strike a delicate balance between safety and efficiency (<xref rid="bib126" ref-type="bibr">Vershilova, 1961</xref>). In addition, the pathogenesis of <italic>Brucella</italic> and the mechanisms by which it escapes host immune responses and perpetuates infection are not fully understood. Moreover, the uniqueness and complexity of <italic>Brucella</italic> itself caused by multiple strains and genetic variants that allow it to evade and manipulate the host immune system, posing a significant obstacle to vaccine development (<xref rid="bib84" ref-type="bibr">Masjedian Jezi, Razavi, Mirnejad, &amp; Zamani, 2019</xref>). Given the consistent incidence of human brucellosis, it is imperative to sustain research efforts focused on the development of human vaccines that are both safe and effective, while also providing cross-protection against various strains of <italic>Brucella</italic>.</p>
        <p id="p0100">The management of human brucellosis has greatly depended on controlling animal brucellosis through effective vaccination strategies. Live attenuated vaccines, such as <italic>B.&#xA0;abortus</italic> S19/A19, <italic>B.&#xA0;melitensis</italic> Rev1, and <italic>B.&#xA0;suis</italic> S2, are widely used to control brucellosis in animals. While these vaccines have been successful in producing long-lasting antibodies, they have drawbacks such as interfering with serologic diagnosis, antibiotic resistance, and residual toxicity (<xref rid="bib49" ref-type="bibr">Horwell &amp; Van Drimmelen, 1971</xref>; <xref rid="bib71" ref-type="bibr">Li, Shi, et&#xA0;al., 2015</xref>; <xref rid="bib120" ref-type="bibr">Truong, Cho, Kim, Park, &amp; Hahn, 2015</xref>; <xref rid="bib125" ref-type="bibr">Verger, Grayon, Zundel, Lechopier, &amp; Olivier-Bernardin, 1995</xref>; <xref rid="bib155" ref-type="bibr">Zhu et&#xA0;al., 2016</xref>). In recent years, advances in molecular microbiology and genetic engineering have led to the development of new <italic>Brucella</italic> vaccines with equal or higher protective efficacy, including vaccines with live attenuated vaccines with gene deletion, subunit vaccines, DNA vaccines, and vector vaccines (<xref rid="bib45" ref-type="bibr">Heidary et&#xA0;al., 2022</xref>). These vaccines aim to induce a strong immune response and have shown promising immunogenicity (<xref rid="tbl2" ref-type="table">Table&#xA0;2</xref>). The proteins Omp31/28/25/19/16, ribosomal proteins L7/12, type IV secretion system-associated protein VirB12, and cytoplasmic binding protein P39 are strongly linked to the virulence and immunogenicity of <italic>Brucella</italic> (<xref rid="bib45" ref-type="bibr">Heidary et&#xA0;al., 2022</xref>). Subunit vaccines offer non-infectious and cross-protective benefits but suffer from weak antigenicity, instability, and short half-life (<xref rid="bib89" ref-type="bibr">Moyle &amp; Toth, 2013</xref>). DNA vaccines are used to develop safe and effective <italic>Brucella</italic> vaccines, stimulating immune responses but not consistently providing protection (<xref rid="bib123" ref-type="bibr">Velikovsky et&#xA0;al., 2000</xref>). Vector vaccines introduce antigen genes into attenuated bacteria or viruses to induce immunoprotective responses, such as with <italic>S.&#xA0;typhimurium</italic> and <italic>Adenovirus</italic> vectors (<xref rid="bib46" ref-type="bibr">Hewawaduge, Senevirathne, &amp; Lee, 2020</xref>; <xref rid="bib124" ref-type="bibr">Vellinga et&#xA0;al., 2014</xref>). Although these vaccines enhance immunogenicity, they may carry pathogenic risks different from natural proteins. The live attenuated vaccines with virulence gene deletions show higher safety profiles compared to traditional vaccines, promoting T cell proliferation, pro-inflammatory cytokine expression, and antibody production, The live attenuated vaccines with virulence gene deletions hold promise as vaccine candidates for humans but need consideration regarding risks of reversion to virulence and antibiotic resistance (<xref rid="bib97" ref-type="bibr">Perkins, Smither, &amp; Atkins, 2010</xref>; <xref rid="bib121" ref-type="bibr">Truong, Cho, Park, Kim, &amp; Hahn, 2016</xref>). Additional factors to consider include the use of adjuvants, immunomodulators, and antigen-presenting systems to enhance immune response levels. Overall, the research and development of improved <italic>Brucella</italic> vaccines have garnered significant attention, offering potential alternatives to live attenuated vaccines with enhanced safety and effectiveness.<table-wrap position="float" id="tbl2"><label>Table&#xA0;2</label><caption><p>Brucella vaccines.</p></caption><alt-text id="alttext0025">Table&#xA0;2</alt-text><table frame="hsides" rules="groups"><thead><tr><th>Type</th><th>Name of vaccine/Antigens</th><th>Vector</th><th>Advantage</th><th>Disadvantage</th><th>References</th></tr></thead><tbody><tr><td rowspan="7" align="left">Live-attenuated vaccines</td><td align="left"><italic>B.&#xA0;abortus</italic> strains S19/<italic>A19</italic></td><td rowspan="3" align="left">No</td><td rowspan="3" align="left">High and wide immunoprotective capacity</td><td rowspan="3" align="left">Interference with serological diagnosis;<break/>Limited protective host range;<break/>Antibiotic resistance.</td><td rowspan="2" align="left"><xref rid="bib120" ref-type="bibr">Truong et al. 2015</xref></td></tr><tr><td align="left"><italic>B.&#xA0;melitensis strain Rev1</italic></td></tr><tr><td align="left"><italic>B.&#xA0;suis</italic> strain S2</td><td align="left"><xref rid="bib125" ref-type="bibr">Verger et&#xA0;al., 1995</xref>; <xref rid="bib155" ref-type="bibr">Zhu et&#xA0;al., 2016</xref></td></tr><tr><td align="left">B. abortus (&#x25B3;cydC, cydD)/(&#x25B3;cydC1, purD)/(&#x25B3;norD, znuA)</td><td align="left">No</td><td align="left">Induction of significant levels of IgG antibodies;<break/>Induction of higher levels of IFN-&#x3B3;, IL-10, IL-4 and TNF-&#x3B1;;<break/>Provides security and stability.</td><td rowspan="4" align="left">Risk of reintensification of vaccine strains</td><td align="left"><xref rid="bib76" ref-type="bibr">Li et&#xA0;al., 2017b</xref>, <xref rid="bib77" ref-type="bibr">2017c</xref>; <xref rid="bib121" ref-type="bibr">Truong et&#xA0;al., 2016</xref></td></tr><tr><td align="left"><italic>B.&#xA0;melitensis</italic> 16M &#x25B3;<italic>hfq/</italic>&#x25B3; TcfSR/&#x25B3; mucR</td><td align="left">No</td><td align="left">Induction of significant levels of IgG antibodies;<break/>Induction of higher levels of IFN-and IL-4;<break/>Reduced pathologic damage.</td><td align="left"><xref rid="bib4" ref-type="bibr">Arenas-Gamboa, Rice-Ficht, Kahl-Mcdonagh, &amp; Ficht, 2011</xref>; <xref rid="bib66" ref-type="bibr">Lei et&#xA0;al., 2015</xref>; <xref rid="bib78" ref-type="bibr">Li, Zhang, et&#xA0;al., 2015</xref>; <xref rid="bib144" ref-type="bibr">Zhang et&#xA0;al., 2013</xref></td></tr><tr><td align="left"><italic>B.&#xA0;melitensis</italic> M5-90 &#x25B3;<italic>bp26/</italic>&#x25B3;<italic>vjbR/</italic>&#x25B3; <italic>manB/</italic>&#x25B3;wboA</td><td align="left">No</td><td align="left">Reduced virulence and higher level of immune protection;<break/>Induction of significant levels of IgG antibodies;<break/>Induction of higher levels of IFNs and IL-4;<break/>Ability to differentiate between serotypes of infected and vaccinated animals.</td><td align="left"><xref rid="bib71" ref-type="bibr">Li, Shi, et&#xA0;al., 2015</xref>; <xref rid="bib72" ref-type="bibr">Li, Tong, et al., 2017</xref>; <xref rid="bib75" ref-type="bibr">Li et al., 2018</xref>; <xref rid="bib146" ref-type="bibr">Zhang, Yin, et al., 2017</xref></td></tr><tr><td align="left"><italic>B.&#xA0;suis</italic> &#x25B3;<italic>pgm</italic></td><td align="left">No</td><td align="left">Induces strong cellular immune responses and pro-inflammatory factors production; virulence reduction.</td><td align="left"><xref rid="bib26" ref-type="bibr">Czibener, Del Giudice, Spera, Fulgenzi, and Ugalde, 2016</xref></td></tr></tbody></table><table frame="hsides" rules="groups"><thead><tr><th>Type</th><th>Name of vaccine/Antigens</th><th>Vector</th><th>Advantage</th><th>Disadvantage</th><th>References</th></tr></thead><tbody><tr><td rowspan="4" align="left">Subunit vaccines</td><td align="left">Omp25-Omp31</td><td align="left">No</td><td align="left">Induction of higher levels of IFN-&#x3B3; and TNF-&#x3B1;;<break/>Activation of Th1 type immune response.</td><td rowspan="4" align="left">Low levels of protective antibodies</td><td align="left"><xref rid="bib86" ref-type="bibr">Mohammadi, 2021</xref></td></tr><tr><td align="left">Omp25-L7/12</td><td align="left">No</td><td align="left">Induction of significant levels of IgG antibodies;<break/>Activation of Th2 type immune response.</td><td align="left"><xref rid="bib43" ref-type="bibr">Gupta, Mohan, Somani, Aggarwal, and Bhatnagar, 2020</xref></td></tr><tr><td align="left">Omp16/19/28-L7/12</td><td align="left">No</td><td align="left">Induction of higher levels of TNF-&#x3B1;, IL-6 and MCP-1;<break/>Activation of Th1 type immune response.</td><td align="left"><xref rid="bib53" ref-type="bibr">Huy et al., 2020</xref></td></tr><tr><td align="left">Omp31&#x3001;BP26&#x3001;BLS&#x3001;DnaK and L7/12</td><td align="left">No</td><td align="left">dominant antigen epitope vaccine (DAEV);<break/>Induction of significant levels of IgG antibodies;<break/>Induction of higher levels of TNF-&#x3B1;&#xFF0C;IFN-&#x3B3; and IL-10;<break/>Induction of mixed Th1 and Th2 immune responses.</td><td align="left"><xref rid="bib44" ref-type="bibr">Gupta, Singh, Gupta, and Bhatnagar, 2019</xref></td></tr><tr><td rowspan="5" align="left">Vector vaccines</td><td align="left">Omp19, Cu-Zn superoxide dismutase (SOD)</td><td align="left"><italic>S.&#xA0;typhimurium</italic></td><td align="left">SOD induces high level of IFN-&#x3B3; expression;<break/>Omp19 induces the production of higher titers of IgG antibodies;<break/>Induction of mixed Th1 and Th2 immune responses.</td><td align="left">Presence of potentially pathogenic antigens</td><td align="left"><xref rid="bib46" ref-type="bibr">Hewawaduge et al., 2020</xref></td></tr><tr><td align="left">Omp 16/19, L7/12, and Cu-Zn SOD</td><td align="left">Influenza viral vector (rIVV) subtype H5N1</td><td align="left">Immunization effects similar to live attenuated vaccines</td><td align="left">Presence of potentially pathogenic antigens;</td><td align="left"><xref rid="bib13" ref-type="bibr">Bugybayeva et al., 2020</xref></td></tr><tr><td align="left">L7/12 and BCSP31</td><td align="left">Adenovirus</td><td align="left">Induction of significant levels of IgG antibodies;<break/>Induction of higher levels of IL-12 and IL-10.</td><td align="left">Weaker than live attenuated A19 vaccine;<break/>Presence of potentially pathogenic antigens</td><td align="left"><xref rid="bib124" ref-type="bibr">Vellinga et al., 2014</xref></td></tr><tr><td align="left">OMP19</td><td align="left"><italic>L.&#xA0;casei</italic></td><td align="left">Induction of higher levels of IFN-&#x3B3;&#x3001;IL-2 and IL-4;<break/>Activation of Th1 and Th2 type immune response.</td><td rowspan="2" align="left">Presence of potentially pathogenic antigens</td><td align="left"><xref rid="bib87" ref-type="bibr">Mohammadi and Golchin, 2020</xref></td></tr><tr><td align="left">Cu-Zn SOD</td><td align="left"><italic>L lactis</italic></td><td align="left">Induces mucosal type 2 immune responses;<break/>SOD induces systemic and mucosal specific immune responses.</td><td align="left"><xref rid="bib101" ref-type="bibr">S&#xE1;ez, Fern&#xE1;ndez, Rivera, Andrews, and O&#xF1;ate, 2012</xref></td></tr></tbody></table><table frame="hsides" rules="groups"><thead><tr><th>Type</th><th>Name of vaccine/Antigens</th><th>Vector</th><th>Advantage</th><th>Disadvantage</th><th>References</th></tr></thead><tbody><tr><td rowspan="3" align="left">DNA vaccines</td><td align="left">Omp25-Omp31</td><td align="left">pcDNA3.1</td><td align="left">Flexible design and high security;<break/>Induces the production of high levels of IgG antibodies and IFN-&#x3B3;;<break/>Activates strong humoral and cellular immunity.</td><td align="left">Lower levels of antibody protection</td><td align="left"><xref rid="bib112" ref-type="bibr">Shojaei, Tahmoorespur, Soltani, and Sekhavati, 2018</xref></td></tr><tr><td align="left">Cu-Zn SOD</td><td align="left">pcDNA</td><td align="left">DNA epitope vaccines;<break/>Flexible design and high security;<break/>Induction of high levels of IgG antibodies, IFN-&#x3B3; and Th1 immunoreactivity.</td><td align="left">No induction of IL-4 production and Th2 immune response;<break/>Lower levels of antibody protection.</td><td align="left"><xref rid="bib36" ref-type="bibr">Escalona, S&#xE1;ez, and O&#xF1;ate, 2017</xref></td></tr><tr><td align="left">BvrR</td><td align="left">No</td><td align="left">Flexible design and high security;<break/>Activation of Th1 type immune response.<break/>Induction of IFN-&#x3B3; expression and T cell proliferation.</td><td align="left">Low antibody titer</td><td align="left"><xref rid="bib18" ref-type="bibr">Chen, Liu, Zhao, and Wang, 2019</xref></td></tr><tr><td rowspan="3" align="left">Nanoparticle based vaccines</td><td align="left">Chimeric antigen<break/>TF/Bp26/Omp31 (TBO)</td><td align="left">Glycine nanoparticles</td><td align="left">Induce high levels of IgG and IgA antibodies;<break/>Induction of cellular and humoral immune responses.</td><td rowspan="3" align="left">Low levels of antibody protection</td><td align="left"><xref rid="bib58" ref-type="bibr">Karevan, Ahmadi, Taheri, and Fasihi-Ramandi, 2021</xref></td></tr><tr><td align="left">Malate dehydrogenase (rMdh),<break/>Omp 10/19</td><td align="left">Carbon nanosheet&#xFF08;CNs&#xFF09;</td><td align="left">Induce increased expression of IgG and IgA antibodies, IFN-&#x3B3; and IL-4;<break/>Activation of Th1 and Th2 type immune response.</td><td align="left"><xref rid="bib111" ref-type="bibr">Shim et al., 2020</xref></td></tr><tr><td align="left">L7/L12</td><td align="left">PLGA nanoparticles</td><td align="left">Induction of high levels of IgG antibody titers and IFN-&#x3B3; production;<break/>Activation of Th1 type immune response.<break/>Reduction of pathological damage</td><td align="left"><xref rid="bib115" ref-type="bibr">Singh, Somani, Aggarwal, and Bhatnagar, 2015</xref></td></tr></tbody></table><table frame="hsides" rules="groups"><thead><tr><th>Type</th><th>Name of vaccine/Antigens</th><th>Vector</th><th>Advantage</th><th>Disadvantage</th><th>References</th></tr></thead><tbody><tr><td rowspan="2" align="left">Other vaccines</td><td align="left">bacterial-ghost (BG) 2308 GntR</td><td align="left">No</td><td align="left">High immunogenicity and safety;<break/>Induces high levels of IgG antibodies;<break/>Induction of increased expression of IFN-&#x3B3; and IL-4;<break/>Promotes immune response of CD4<sup>+</sup> and CD8<sup>+</sup> T cells;<break/>Activation of Th1 type immune response</td><td rowspan="2" align="left">Lower lysis efficiency using Gram-negative bacteria as carriers</td><td align="left"><xref rid="bib74" ref-type="bibr">Liu et&#xA0;al., 2015</xref>; <xref rid="bib129" ref-type="bibr">Wang et&#xA0;al., 2020</xref></td></tr><tr><td align="left">L7/L12</td><td align="left"><italic>S.&#xA0;typhimurium</italic></td><td align="left">Induction of significant levels of IgG antibodies;<break/>Induction of higher levels of TFN-&#x3B3; and IL-4;<break/>Significant increase in both CD4<sup>+</sup> and CD8<sup>+</sup> cells;<break/>Lipopolysaccharide (LPS) present in the host produces specific immunity against Salmonella spp.</td><td align="left"><xref rid="bib107" ref-type="bibr">Senevirathne, Hewawaduge, and Lee, 2020</xref></td></tr></tbody></table></table-wrap></p>
      </sec>
    </sec>
    <sec id="sec2">
      <label>2</label>
      <title>Conclusion</title>
      <p id="p0105"><italic>Brucella</italic> has developed potent mechanisms to avoid or undermine host defense mechanisms. <italic>Brucella</italic> displays stealthy methods of invading host cells, cleverly evading detection by PRRs and thereby bypassing immune surveillance. This interplay leads to a prolonged balance between <italic>Brucella</italic> and the host's immune defense, promoting its ability to survive within host cells for an extended period of time.</p>
      <p id="p0110">Understanding the complicated mechanism of <italic>Brucella</italic>-induced host immunosuppression remains a challenging task. <italic>Brucella</italic> not only evades detection to suppress the host's innate and adaptive immune responses but also impacts important cellular processes like apoptosis, pyroptosis, autophagy, and endoplasmic reticulum stress. These mechanisms allow <italic>Brucella</italic> to manipulate cellular functions, promoting its survival within the host. The virulence factors and effector proteins of <italic>Brucella</italic>'s T4SS play a crucial role in stabilizing <italic>Brucella</italic>-containing vacuoles within the endoplasmic reticulum, facilitating replication by manipulating or exploiting host proteins. Further research is needed to fully understand how <italic>Brucella</italic> utilizes these cellular processes for self-replication.</p>
      <p id="p0115">No vaccine against human brucellosis exists to date. Therefore, control of human brucellosis relies heavily on the control of animal brucellosis through vaccination. The most effective protection against <italic>Brucella</italic> invasion is provided by live attenuated vaccines (<xref rid="bib104" ref-type="bibr">Sancho, Tejedor, Sidhu-Mu&#xF1;oz, Fern&#xE1;ndez-Lago, &amp; Vizca&#xED;no, 2014</xref>). While these vaccines produce long-lasting antibodies, they have drawbacks such as interfering with standard serologic diagnostics, antibiotic resistance, and residual toxicity. The key to the development of more effective brucellosis vaccines is to induce a significant Th1 immune response and to provide a higher level of protection (<xref rid="bib27" ref-type="bibr">de Figueiredo, Ficht, Rice-Ficht, Rossetti, &amp; Adams, 2015</xref>; <xref rid="bib94" ref-type="bibr">Pascual et&#xA0;al., 2018</xref>). In order to design and develop new strategies to enhance the immunogenicity of new vaccines, we still need to further elucidate the pathogenic mechanism of <italic>Brucella</italic>, and also need to conduct in-depth explorations on the selection of antigens, animal models, effective adjuvants and delivery vectors.</p>
      <p id="p0120">In summary, this manuscript provides a comprehensive review of <italic>Brucella</italic>'s pathogenic mechanism and its strategies to evade host defense responses. However, there is still much to explore regarding the specific factors responsible for host resistance to <italic>Brucella</italic> infection. Further exploration is needed to understand the influence of host genetic background, immune status, and physiological conditions on <italic>Brucella</italic> infection to help reveal individual differences in susceptibility and severity of infection, providing evidence for developing more personalized and precise therapies. Moreover, the differences in immune responses triggered by acute and chronic infections of <italic>Brucella</italic> are worth investigating, as these differences can have implications for interactions between <italic>Brucella</italic> and the host immune system, including the dynamics of host immune responses and differences in <italic>Brucella</italic> evasion strategies. This understanding can contribute to the development of more effective prevention and provide more precise treatment strategies for acute and chronic infections. Most importantly, <italic>Brucella</italic> has the ability to invade host cells and survive within them, yet the mechanisms underlying its intracellular survival remain incompletely understood. Therefore, further research is needed to elucidate how <italic>Brucella</italic> evades immune surveillance and clearance within host cells. Our understanding of the direct interactions between <italic>Brucella</italic>-secreted proteins and host proteins, which are crucial for <italic>Brucella</italic>'s ability to cause disease, is also limited. To further fulfill our knowledge, it is necessary to conduct additional studies using reliable screening systems such as affinity tag purification mass spectrometry, the transposon system, and the CRISPR-Cas9 screening system. These investigations will help us better understand the intricate molecular interactions between <italic>Brucella</italic> and the host, leading to the development of therapeutic agents and diagnostic tools for brucellosis.</p>
    </sec>
    <sec id="sec3">
      <title>Conflict of interest</title>
      <p id="p0125">The authors state that the manuscript was conducted without any commercial or financial relationships that could be considered as a potential conflict of interest.</p>
    </sec>
    <sec sec-type="COI-statement">
      <title>Declaration of competing interest</title>
      <p id="p0130">The authors state that the manuscript was conducted without any commercial or financial relationships that could be considered as a potential conflict of interest.</p>
    </sec>
  </body>
  <back>
    <ref-list id="cebib0010">
      <title>References</title>
      <ref id="bib1">
        <element-citation publication-type="journal" id="sref1">
          <person-group person-group-type="author">
            <name>
              <surname>Ali</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Waris</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Khan</surname>
              <given-names>M.A.</given-names>
            </name>
            <name>
              <surname>Asim</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Khan</surname>
              <given-names>A.U.</given-names>
            </name>
            <name>
              <surname>Khan</surname>
              <given-names>S.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Recent advancement, immune responses, and mechanism of action of various vaccines against intracellular bacterial infections</article-title>
          <source>Life Sciences</source>
          <volume>314</volume>
          <year>2023</year>
          <object-id pub-id-type="publisher-id">121332</object-id>
        </element-citation>
      </ref>
      <ref id="bib2">
        <element-citation publication-type="journal" id="sref2">
          <person-group person-group-type="author">
            <name>
              <surname>Andersen-Nissen</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>K.D.</given-names>
            </name>
            <name>
              <surname>Strobe</surname>
              <given-names>K.L.</given-names>
            </name>
            <name>
              <surname>Barrett</surname>
              <given-names>S.L.</given-names>
            </name>
            <name>
              <surname>Cookson</surname>
              <given-names>B.T.</given-names>
            </name>
            <name>
              <surname>Logan</surname>
              <given-names>S.M.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Evasion of Toll-like receptor 5 by flagellated bacteria</article-title>
          <source>Proceedings of the National Academy of Sciences of the U S A</source>
          <volume>102</volume>
          <year>2005</year>
          <fpage>9247</fpage>
          <lpage>9252</lpage>
        </element-citation>
      </ref>
      <ref id="bib3">
        <element-citation publication-type="journal" id="sref3">
          <person-group person-group-type="author">
            <name>
              <surname>An</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Guo</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Liuyu</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Zhong</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>Z.D.</given-names>
            </name>
          </person-group>
          <article-title>USP2 promotes experimental colitis and bacterial infections by inhibiting the proliferation of myeloid cells and remodeling the extracellular matrix network</article-title>
          <source>Cell Insight</source>
          <volume>1</volume>
          <year>2022</year>
          <object-id pub-id-type="publisher-id">100047</object-id>
        </element-citation>
      </ref>
      <ref id="bib4">
        <element-citation publication-type="journal" id="sref4"><person-group person-group-type="author"><name><surname>Arenas-Gamboa</surname><given-names>A.M.</given-names></name><name><surname>Rice-Ficht</surname><given-names>A.C.</given-names></name><name><surname>Kahl-Mcdonagh</surname><given-names>M.M.</given-names></name><name><surname>Ficht</surname><given-names>T.A.</given-names></name></person-group><article-title>Protective efficacy and safety of Brucella melitensis 16M&#x394;mucR against intraperitoneal and aerosol challenge in BALB/c mice</article-title><source>Infection and Immunity</source><volume>79</volume><year>2011</year><fpage>3653</fpage><lpage>3658</lpage><pub-id pub-id-type="pmid">21708998</pub-id>
</element-citation>
      </ref>
      <ref id="bib5">
        <element-citation publication-type="journal" id="sref5"><person-group person-group-type="author"><name><surname>Avila-Calder&#xF3;n</surname><given-names>E.D.</given-names></name><name><surname>Flores-Romo</surname><given-names>L.</given-names></name><name><surname>Sharon</surname><given-names>W.</given-names></name><name><surname>Donis-Maturano</surname><given-names>L.</given-names></name><name><surname>Becerril-Garc&#xED;A</surname><given-names>M.A.</given-names></name><name><surname>Arreola</surname><given-names>M.G.A.</given-names></name><etal/></person-group><article-title>Dendritic cells and Brucella spp. interaction: The sentinel host and the stealthy pathogen</article-title><source>Folia Microbiol (Praha)</source><volume>65</volume><year>2020</year><fpage>1</fpage><lpage>16</lpage><pub-id pub-id-type="pmid">30783994</pub-id>
</element-citation>
      </ref>
      <ref id="bib6">
        <element-citation publication-type="journal" id="sref6"><person-group person-group-type="author"><name><surname>Bai</surname><given-names>Q.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Wu</surname><given-names>X.</given-names></name><name><surname>Shao</surname><given-names>J.</given-names></name><name><surname>Sun</surname><given-names>M.</given-names></name><name><surname>Yin</surname><given-names>D.</given-names></name></person-group><article-title>Comparative analysis of the main outer membrane proteins of Brucella in the diagnosis of brucellosis</article-title><source>Biochemical and Biophysical Research Communications</source><volume>560</volume><year>2021</year><fpage>126</fpage><lpage>131</lpage><pub-id pub-id-type="pmid">33989903</pub-id>
</element-citation>
      </ref>
      <ref id="bib7">
        <element-citation publication-type="journal" id="sref7"><person-group person-group-type="author"><name><surname>Baldwin</surname><given-names>C.L.</given-names></name><name><surname>Goenka</surname><given-names>R.</given-names></name></person-group><article-title>Host immune responses to the intracellular bacteria Brucella: Does the bacteria instruct the host to facilitate chronic infection?</article-title><source>Critical Reviews in Immunology</source><volume>26</volume><year>2006</year><fpage>407</fpage><lpage>442</lpage><pub-id pub-id-type="pmid">17341186</pub-id>
</element-citation>
      </ref>
      <ref id="bib8">
        <element-citation publication-type="journal" id="sref8">
          <person-group person-group-type="author">
            <name>
              <surname>Barquero-Calvo</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Chaves-Olarte</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Weiss</surname>
              <given-names>D.S.</given-names>
            </name>
            <name>
              <surname>Guzm&#xE1;N-Verri</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Chac&#xF3;N-D&#xED;AZ</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Rucavado</surname>
              <given-names>A.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Brucella abortus uses a stealthy strategy to avoid activation of the innate immune system during the onset of infection</article-title>
          <source>PLoS One</source>
          <volume>2</volume>
          <year>2007</year>
          <object-id pub-id-type="publisher-id">e631</object-id>
        </element-citation>
      </ref>
      <ref id="bib9">
        <element-citation publication-type="journal" id="sref9"><person-group person-group-type="author"><name><surname>Bestebroer</surname><given-names>J.</given-names></name><name><surname>V'Kovski</surname><given-names>P.</given-names></name><name><surname>Mauthe</surname><given-names>M.</given-names></name><name><surname>Reggiori</surname><given-names>F.</given-names></name></person-group><article-title>Hidden behind autophagy: The unconventional roles of ATG proteins</article-title><source>Traffic</source><volume>14</volume><year>2013</year><fpage>1029</fpage><lpage>1041</lpage><pub-id pub-id-type="pmid">23837619</pub-id>
</element-citation>
      </ref>
      <ref id="bib10">
        <element-citation publication-type="journal" id="sref10"><person-group person-group-type="author"><name><surname>Billard</surname><given-names>E.</given-names></name><name><surname>Dornand</surname><given-names>J.</given-names></name><name><surname>Gross</surname><given-names>A.</given-names></name></person-group><article-title>Brucella suis prevents human dendritic cell maturation and antigen presentation through regulation of tumor necrosis factor alpha secretion</article-title><source>Infection and Immunity</source><volume>75</volume><year>2007</year><fpage>4980</fpage><lpage>4989</lpage><pub-id pub-id-type="pmid">17635859</pub-id>
</element-citation>
      </ref>
      <ref id="bib11">
        <element-citation publication-type="journal" id="sref11">
          <person-group person-group-type="author">
            <name>
              <surname>Boschiroli</surname>
              <given-names>M.L.</given-names>
            </name>
            <name>
              <surname>Ouahrani-Bettache</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Foulongne</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Michaux-Charachon</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Bourg</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Allardet-Servent</surname>
              <given-names>A.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The Brucella suis virB operon is induced intracellularly in macrophages</article-title>
          <source>Proceedings of the National Academy of Sciences of the U S A</source>
          <volume>99</volume>
          <year>2002</year>
          <fpage>1544</fpage>
          <lpage>1549</lpage>
        </element-citation>
      </ref>
      <ref id="bib12">
        <element-citation publication-type="journal" id="sref12"><person-group person-group-type="author"><name><surname>Bronner</surname><given-names>D.N.</given-names></name><name><surname>O'Riordan</surname><given-names>M.X.</given-names></name><name><surname>He</surname><given-names>Y.</given-names></name></person-group><article-title>Caspase-2 mediates a Brucella abortus RB51-induced hybrid cell death having features of apoptosis and pyroptosis</article-title><source>Frontiers in Cellular and Infection Microbiology</source><volume>3</volume><year>2013</year><fpage>83</fpage><pub-id pub-id-type="pmid">24350060</pub-id>
</element-citation>
      </ref>
      <ref id="bib13">
        <element-citation publication-type="journal" id="sref13">
          <person-group person-group-type="author">
            <name>
              <surname>Bugybayeva</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Ryskeldinova</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Zinina</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Sarmykova</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Assanzhanova</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Kydyrbayev</surname>
              <given-names>Z.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Development of human vectored brucellosis vaccine formulation: Assessment of safety and protectiveness of influenza viral vectors expressing Brucella immunodominant proteins in mice and Guinea pigs</article-title>
          <source>BioMed Research International</source>
          <volume>2020</volume>
          <year>2020</year>
          <object-id pub-id-type="publisher-id">1438928</object-id>
        </element-citation>
      </ref>
      <ref id="bib14">
        <element-citation publication-type="journal" id="sref14"><person-group person-group-type="author"><name><surname>Buttigieg</surname><given-names>S.C.</given-names></name><name><surname>Savic</surname><given-names>S.</given-names></name><name><surname>Cauchi</surname><given-names>D.</given-names></name><name><surname>Lautier</surname><given-names>E.</given-names></name><name><surname>Canali</surname><given-names>M.</given-names></name><name><surname>Aragrande</surname><given-names>M.</given-names></name></person-group><article-title>Brucellosis control in Malta and Serbia: A one health evaluation</article-title><source>Frontiers in Veterinary Science</source><volume>5</volume><year>2018</year><fpage>147</fpage><pub-id pub-id-type="pmid">30018972</pub-id>
</element-citation>
      </ref>
      <ref id="bib15">
        <element-citation publication-type="journal" id="sref15">
          <person-group person-group-type="author">
            <name>
              <surname>Byndloss</surname>
              <given-names>M.X.</given-names>
            </name>
            <name>
              <surname>Tsai</surname>
              <given-names>A.Y.</given-names>
            </name>
            <name>
              <surname>Walker</surname>
              <given-names>G.T.</given-names>
            </name>
            <name>
              <surname>Miller</surname>
              <given-names>C.N.</given-names>
            </name>
            <name>
              <surname>Young</surname>
              <given-names>B.M.</given-names>
            </name>
            <name>
              <surname>English</surname>
              <given-names>B.C.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Brucella abortus infection of placental trophoblasts triggers endoplasmic reticulum stress-mediated cell death and fetal loss via type IV secretion system-dependent activation of CHOP</article-title>
          <source>mBio</source>
          <volume>10, e01538-19</volume>
          <year>2019</year>
        </element-citation>
      </ref>
      <ref id="bib16">
        <element-citation publication-type="journal" id="sref16"><person-group person-group-type="author"><name><surname>Cardoso</surname><given-names>P.G.</given-names></name><name><surname>Macedo</surname><given-names>G.C.</given-names></name><name><surname>Azevedo</surname><given-names>V.</given-names></name><name><surname>Oliveira</surname><given-names>S.C.</given-names></name></person-group><article-title>Brucella spp noncanonical LPS: Structure, biosynthesis, and interaction with host immune system</article-title><source>Microbial Cell Factories</source><volume>5</volume><year>2006</year><fpage>13</fpage><pub-id pub-id-type="pmid">16556309</pub-id>
</element-citation>
      </ref>
      <ref id="bib17">
        <element-citation publication-type="journal" id="sref17">
          <person-group person-group-type="author">
            <name>
              <surname>Celli</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>The intracellular life cycle of Brucella spp</article-title>
          <source>Microbiology Spectrum</source>
          <volume>7, 10.1128</volume>
          <year>2019</year>
        </element-citation>
      </ref>
      <ref id="bib18">
        <element-citation publication-type="journal" id="sref18"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>B.</given-names></name><name><surname>Liu</surname><given-names>B.</given-names></name><name><surname>Zhao</surname><given-names>Z.</given-names></name><name><surname>Wang</surname><given-names>G.</given-names></name></person-group><article-title>Evaluation of a DNA vaccine encoding Brucella BvrR in BALB/c mice</article-title><source>Molecular Medicine Reports</source><volume>19</volume><year>2019</year><fpage>1302</fpage><lpage>1308</lpage><pub-id pub-id-type="pmid">30569140</pub-id>
</element-citation>
      </ref>
      <ref id="bib19">
        <element-citation publication-type="journal" id="sref19">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>Y.G.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>Endomembrane remodeling in SARS-CoV-2 infection</article-title>
          <source>Cell Insight</source>
          <volume>1</volume>
          <year>2022</year>
          <object-id pub-id-type="publisher-id">100031</object-id>
        </element-citation>
      </ref>
      <ref id="bib21">
        <element-citation publication-type="journal" id="sref21"><person-group person-group-type="author"><name><surname>Cooper</surname><given-names>M.D.</given-names></name><name><surname>Alder</surname><given-names>M.N.</given-names></name></person-group><article-title>The evolution of adaptive immune systems</article-title><source>Cell</source><volume>124</volume><year>2006</year><fpage>815</fpage><lpage>822</lpage><pub-id pub-id-type="pmid">16497590</pub-id>
</element-citation>
      </ref>
      <ref id="bib22">
        <element-citation publication-type="journal" id="sref22">
          <person-group person-group-type="author">
            <name>
              <surname>Copin</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Vitry</surname>
              <given-names>M.A.</given-names>
            </name>
            <name>
              <surname>Hanot Mambres</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Machelart</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>DE Trez</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Vanderwinden</surname>
              <given-names>J.M.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>In situ microscopy analysis reveals local innate immune response developed around Brucella infected cells in resistant and susceptible mice</article-title>
          <source>PLoS Pathogens</source>
          <volume>8</volume>
          <year>2012</year>
          <object-id pub-id-type="publisher-id">e1002575</object-id>
        </element-citation>
      </ref>
      <ref id="bib23">
        <element-citation publication-type="journal" id="sref23"><person-group person-group-type="author"><name><surname>Costa Franco</surname><given-names>M.M.S.</given-names></name><name><surname>Marim</surname><given-names>F.M.</given-names></name><name><surname>Alves-Silva</surname><given-names>J.</given-names></name><name><surname>Cerqueira</surname><given-names>D.</given-names></name><name><surname>Rungue</surname><given-names>M.</given-names></name><name><surname>Tavares</surname><given-names>I.P.</given-names></name><etal/></person-group><article-title>AIM2 senses Brucella abortus DNA in dendritic cells to induce IL-1&#x3B2; secretion, pyroptosis and resistance to bacterial infection in mice</article-title><source>Microbes and Infection</source><volume>21</volume><year>2019</year><fpage>85</fpage><lpage>93</lpage><pub-id pub-id-type="pmid">30248400</pub-id>
</element-citation>
      </ref>
      <ref id="bib24">
        <element-citation publication-type="journal" id="sref24"><person-group person-group-type="author"><name><surname>Costa Franco</surname><given-names>M.M.</given-names></name><name><surname>Marim</surname><given-names>F.</given-names></name><name><surname>Guimar&#xE3;ES</surname><given-names>E.S.</given-names></name><name><surname>Assis</surname><given-names>N.R.G.</given-names></name><name><surname>Cerqueira</surname><given-names>D.M.</given-names></name><name><surname>Alves-Silva</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Brucella abortus triggers a cGAS-independent STING pathway to induce host protection that involves guanylate-binding proteins and inflammasome activation</article-title><source>The Journal of Immunology</source><volume>200</volume><year>2018</year><fpage>607</fpage><lpage>622</lpage><pub-id pub-id-type="pmid">29203515</pub-id>
</element-citation>
      </ref>
      <ref id="bib25">
        <element-citation publication-type="journal" id="sref25"><person-group person-group-type="author"><name><surname>Cui</surname><given-names>B.</given-names></name><name><surname>Liu</surname><given-names>W.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>DU</surname><given-names>Q.</given-names></name><name><surname>Zhao</surname><given-names>X.</given-names></name><etal/></person-group><article-title>Brucella Omp25 upregulates miR-155, miR-21-5p, and miR-23b to inhibit interleukin-12 production via modulation of programmed death-1 signaling in human monocyte/macrophages</article-title><source>Frontiers in Immunology</source><volume>8</volume><year>2017</year><fpage>708</fpage><pub-id pub-id-type="pmid">28694807</pub-id>
</element-citation>
      </ref>
      <ref id="bib26">
        <element-citation publication-type="journal" id="sref26"><person-group person-group-type="author"><name><surname>Czibener</surname><given-names>C.</given-names></name><name><surname>Del Giudice</surname><given-names>M.G.</given-names></name><name><surname>Spera</surname><given-names>J.M.</given-names></name><name><surname>Fulgenzi</surname><given-names>F.R.</given-names></name><name><surname>Ugalde</surname><given-names>J.E.</given-names></name></person-group><article-title>Delta-pgm, a new live-attenuated vaccine against Brucella suis</article-title><source>Vaccine</source><volume>34</volume><year>2016</year><fpage>1524</fpage><lpage>1530</lpage><pub-id pub-id-type="pmid">26899373</pub-id>
</element-citation>
      </ref>
      <ref id="bib27">
        <element-citation publication-type="journal" id="sref27"><person-group person-group-type="author"><name><surname>De Figueiredo</surname><given-names>P.</given-names></name><name><surname>Ficht</surname><given-names>T.A.</given-names></name><name><surname>Rice-Ficht</surname><given-names>A.</given-names></name><name><surname>Rossetti</surname><given-names>C.A.</given-names></name><name><surname>Adams</surname><given-names>L.G.</given-names></name></person-group><article-title>Pathogenesis and immunobiology of brucellosis: Review of brucella-host interactions</article-title><source>The American journal of pathology</source><volume>185</volume><year>2015</year><fpage>1505</fpage><lpage>1517</lpage><pub-id pub-id-type="pmid">25892682</pub-id>
</element-citation>
      </ref>
      <ref id="bib28">
        <element-citation publication-type="journal" id="sref28">
          <person-group person-group-type="author">
            <name>
              <surname>De Jong</surname>
              <given-names>M.F.</given-names>
            </name>
            <name>
              <surname>Starr</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Winter</surname>
              <given-names>M.G.</given-names>
            </name>
            <name>
              <surname>Den Hartigh</surname>
              <given-names>A.B.</given-names>
            </name>
            <name>
              <surname>Child</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Knodler</surname>
              <given-names>L.A.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Sensing of bacterial type IV secretion via the unfolded protein response</article-title>
          <source>mBio</source>
          <volume>4</volume>
          <year>2013</year>
          <object-id pub-id-type="publisher-id">e00418</object-id>
          <comment>12</comment>
        </element-citation>
      </ref>
      <ref id="bib29">
        <element-citation publication-type="journal" id="sref29">
          <person-group person-group-type="author">
            <name>
              <surname>Degos</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Hysenaj</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Gonzalez-Espinoza</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Arce-Gorvel</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Gagnaire</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Papadopoulos</surname>
              <given-names>A.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Omp25-dependent engagement of SLAMF1 by Brucella abortus in dendritic cells limits acute inflammation and favours bacterial persistence in vivo</article-title>
          <source>Cellular Microbiology</source>
          <volume>22</volume>
          <year>2020</year>
          <object-id pub-id-type="publisher-id">e13164</object-id>
        </element-citation>
      </ref>
      <ref id="bib30">
        <element-citation publication-type="journal" id="sref30"><person-group person-group-type="author"><name><surname>Delpino</surname><given-names>M.V.</given-names></name><name><surname>Barrionuevo</surname><given-names>P.</given-names></name><name><surname>Macedo</surname><given-names>G.C.</given-names></name><name><surname>Oliveira</surname><given-names>S.C.</given-names></name><name><surname>Genaro</surname><given-names>S.D.</given-names></name><name><surname>Scian</surname><given-names>R.</given-names></name><etal/></person-group><article-title>Macrophage-elicited osteoclastogenesis in response to Brucella abortus infection requires TLR2/MyD88-dependent TNF-&#x3B1; production</article-title><source>Journal of Leukocyte Biology</source><volume>91</volume><year>2012</year><fpage>285</fpage><lpage>298</lpage><pub-id pub-id-type="pmid">22075930</pub-id>
</element-citation>
      </ref>
      <ref id="bib31">
        <element-citation publication-type="journal" id="sref31"><person-group person-group-type="author"><name><surname>Dudek</surname><given-names>A.M.</given-names></name><name><surname>Martin</surname><given-names>S.</given-names></name><name><surname>Garg</surname><given-names>A.D.</given-names></name><name><surname>Agostinis</surname><given-names>P.</given-names></name></person-group><article-title>Immature, semi-mature, and fully mature dendritic cells: Toward a DC-cancer cells interface that augments anticancer immunity</article-title><source>Frontiers in Immunology</source><volume>4</volume><year>2013</year><fpage>438</fpage><pub-id pub-id-type="pmid">24376443</pub-id>
</element-citation>
      </ref>
      <ref id="bib32">
        <element-citation publication-type="journal" id="sref32">
          <person-group person-group-type="author">
            <name>
              <surname>Durward</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Radhakrishnan</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Harms</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Bareiss</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Magnani</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Splitter</surname>
              <given-names>G.A.</given-names>
            </name>
          </person-group>
          <article-title>Active evasion of CTL mediated killing and low quality responding CD8+ T cells contribute to persistence of brucellosis</article-title>
          <source>PLoS One</source>
          <volume>7</volume>
          <year>2012</year>
          <object-id pub-id-type="publisher-id">e34925</object-id>
        </element-citation>
      </ref>
      <ref id="bib33">
        <element-citation publication-type="journal" id="sref33"><person-group person-group-type="author"><name><surname>Eisenberg</surname><given-names>T.</given-names></name><name><surname>Hamann</surname><given-names>H.P.</given-names></name><name><surname>Kaim</surname><given-names>U.</given-names></name><name><surname>Schlez</surname><given-names>K.</given-names></name><name><surname>Seeger</surname><given-names>H.</given-names></name><name><surname>Schauerte</surname><given-names>N.</given-names></name><etal/></person-group><article-title>Isolation of potentially novel Brucella spp. from frogs</article-title><source>Applied and Environmental Microbiology</source><volume>78</volume><year>2012</year><fpage>3753</fpage><lpage>3755</lpage><pub-id pub-id-type="pmid">22407680</pub-id>
</element-citation>
      </ref>
      <ref id="bib34">
        <element-citation publication-type="journal" id="sref34"><person-group person-group-type="author"><name><surname>Eisenberg</surname><given-names>T.</given-names></name><name><surname>Ri&#xDF;E</surname><given-names>K.</given-names></name><name><surname>Schauerte</surname><given-names>N.</given-names></name><name><surname>Geiger</surname><given-names>C.</given-names></name><name><surname>Blom</surname><given-names>J.</given-names></name><name><surname>Scholz</surname><given-names>H.C.</given-names></name></person-group><article-title>Isolation of a novel 'atypical' Brucella strain from a bluespotted ribbontail ray (Taeniura lymma)</article-title><source>Antonie van Leeuwenhoek</source><volume>110</volume><year>2017</year><fpage>221</fpage><lpage>234</lpage><pub-id pub-id-type="pmid">27785661</pub-id>
</element-citation>
      </ref>
      <ref id="bib20">
        <element-citation publication-type="journal" id="sref20"><person-group person-group-type="author"><name><surname>Coloma-Rivero</surname><given-names>R.F.</given-names></name><name><surname>Flores-Concha</surname><given-names>M.</given-names></name><name><surname>Molina</surname><given-names>R.E.</given-names></name><name><surname>Soto-Shara</surname><given-names>R.</given-names></name><name><surname>Cartes</surname><given-names>&#xC1;.</given-names></name><name><surname>O&#xF1;ATE</surname><given-names>&#xC1;</given-names></name></person-group><article-title>Brucella and its hidden flagellar system</article-title><source>Microorganisms</source><volume>10</volume><year>2021</year><fpage>83</fpage><pub-id pub-id-type="pmid">35056531</pub-id>
</element-citation>
      </ref>
      <ref id="bib35">
        <mixed-citation publication-type="other" id="sref35">Elrashedy, A., Gaafar, M., Mousa, W., Nayel, M., Salama, A., Zaghawa, A., Elsify, A. &amp; Dawood, A. S. Immune response and recent advances in diagnosis and control of brucel losis. German Journal of Veterinary Research, 2, 10-24.</mixed-citation>
      </ref>
      <ref id="bib36">
        <element-citation publication-type="journal" id="sref36"><person-group person-group-type="author"><name><surname>Escalona</surname><given-names>E.</given-names></name><name><surname>S&#xE1;EZ</surname><given-names>D.</given-names></name><name><surname>O&#xF1;ATE</surname><given-names>A.</given-names></name></person-group><article-title>Immunogenicity of a multi-epitope DNA vaccine encoding epitopes from Cu-Zn superoxide dismutase and open reading frames of Brucella abortus in mice</article-title><source>Frontiers in Immunology</source><volume>8</volume><year>2017</year><fpage>125</fpage><pub-id pub-id-type="pmid">28232837</pub-id>
</element-citation>
      </ref>
      <ref id="bib37">
        <element-citation publication-type="journal" id="sref37"><person-group person-group-type="author"><name><surname>Ferrero</surname><given-names>M.C.</given-names></name><name><surname>Hielpos</surname><given-names>M.S.</given-names></name><name><surname>Carvalho</surname><given-names>N.B.</given-names></name><name><surname>Barrionuevo</surname><given-names>P.</given-names></name><name><surname>Corsetti</surname><given-names>P.P.</given-names></name><name><surname>Giambartolomei</surname><given-names>G.H.</given-names></name><etal/></person-group><article-title>Key role of Toll-like receptor 2 in the inflammatory response and major histocompatibility complex class ii downregulation in Brucella abortus-infected alveolar macrophages</article-title><source>Infection and Immunity</source><volume>82</volume><year>2014</year><fpage>626</fpage><lpage>639</lpage><pub-id pub-id-type="pmid">24478078</pub-id>
</element-citation>
      </ref>
      <ref id="bib38">
        <element-citation publication-type="journal" id="sref38">
          <person-group person-group-type="author">
            <name>
              <surname>Fugier</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Salcedo</surname>
              <given-names>S.P.</given-names>
            </name>
            <name>
              <surname>DE Chastellier</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Pophillat</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Muller</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Arce-Gorvel</surname>
              <given-names>V.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The glyceraldehyde-3-phosphate dehydrogenase and the small GTPase Rab 2 are crucial for Brucella replication</article-title>
          <source>PLoS Pathogens</source>
          <volume>5</volume>
          <year>2009</year>
          <object-id pub-id-type="publisher-id">e1000487</object-id>
        </element-citation>
      </ref>
      <ref id="bib39">
        <element-citation publication-type="journal" id="sref39"><person-group person-group-type="author"><name><surname>Godfroid</surname><given-names>J.</given-names></name><name><surname>Cloeckaert</surname><given-names>A.</given-names></name><name><surname>Liautard</surname><given-names>J.P.</given-names></name><name><surname>Kohler</surname><given-names>S.</given-names></name><name><surname>Fretin</surname><given-names>D.</given-names></name><name><surname>Walravens</surname><given-names>K.</given-names></name><etal/></person-group><article-title>From the discovery of the Malta fever's agent to the discovery of a marine mammal reservoir, brucellosis has continuously been a re-emerging zoonosis</article-title><source>Veterinary Research</source><volume>36</volume><year>2005</year><fpage>313</fpage><lpage>326</lpage><pub-id pub-id-type="pmid">15845228</pub-id>
</element-citation>
      </ref>
      <ref id="bib40">
        <element-citation publication-type="journal" id="sref40"><person-group person-group-type="author"><name><surname>Gorvel</surname><given-names>J.P.</given-names></name></person-group><article-title>Brucella: A mr "hide" converted into dr jekyll</article-title><source>Microbes and Infection</source><volume>10</volume><year>2008</year><fpage>1010</fpage><lpage>1013</lpage><pub-id pub-id-type="pmid">18664389</pub-id>
</element-citation>
      </ref>
      <ref id="bib41">
        <element-citation publication-type="journal" id="sref41"><person-group person-group-type="author"><name><surname>Gorvel</surname><given-names>J.P.</given-names></name><name><surname>Moreno</surname><given-names>E.</given-names></name></person-group><article-title>Brucella intracellular life: From invasion to intracellular replication</article-title><source>Veterinary Microbiology</source><volume>90</volume><year>2002</year><fpage>281</fpage><lpage>297</lpage><pub-id pub-id-type="pmid">12414149</pub-id>
</element-citation>
      </ref>
      <ref id="bib42">
        <element-citation publication-type="journal" id="sref42"><person-group person-group-type="author"><name><surname>Grill&#xF3;</surname><given-names>M.J.</given-names></name><name><surname>Blasco</surname><given-names>J.M.</given-names></name><name><surname>Gorvel</surname><given-names>J.P.</given-names></name><name><surname>Moriy&#xF3;N</surname><given-names>I.</given-names></name><name><surname>Moreno</surname><given-names>E.</given-names></name></person-group><article-title>What have we learned from brucellosis in the mouse model?</article-title><source>Veterinary Research</source><volume>43</volume><year>2012</year><fpage>29</fpage><pub-id pub-id-type="pmid">22500859</pub-id>
</element-citation>
      </ref>
      <ref id="bib43">
        <element-citation publication-type="book" id="sref43">
          <person-group person-group-type="author">
            <name>
              <surname>Gupta</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Mohan</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Somani</surname>
              <given-names>V.K.</given-names>
            </name>
            <name>
              <surname>Aggarwal</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Bhatnagar</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <series>Simultaneous immunization with Omp25 and L7/L12 provides protection against brucellosis in mice</series>
          <year>2020</year>
          <comment>Pathogens, 9, 152</comment>
        </element-citation>
      </ref>
      <ref id="bib44">
        <element-citation publication-type="journal" id="sref44">
          <person-group person-group-type="author">
            <name>
              <surname>Gupta</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Singh</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Gupta</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Bhatnagar</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>A combined subunit vaccine comprising BP26, Omp25 and L7/L12 against brucellosis</article-title>
          <source>Pathog Dis</source>
          <volume>77, ftaa002</volume>
          <year>2019</year>
        </element-citation>
      </ref>
      <ref id="bib45">
        <element-citation publication-type="journal" id="sref45">
          <person-group person-group-type="author">
            <name>
              <surname>Heidary</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Dashtbin</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Ghanavati</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Mahdizade Ari</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Bostanghadiri</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Darbandi</surname>
              <given-names>A.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Evaluation of brucellosis vaccines: A comprehensive review</article-title>
          <source>Frontiers in Veterinary Science</source>
          <volume>9</volume>
          <year>2022</year>
          <object-id pub-id-type="publisher-id">925773</object-id>
        </element-citation>
      </ref>
      <ref id="bib46">
        <element-citation publication-type="journal" id="sref46">
          <person-group person-group-type="author">
            <name>
              <surname>Hewawaduge</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Senevirathne</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>J.H.</given-names>
            </name>
          </person-group>
          <article-title>Enhancement of host infectivity, immunity, and protective efficacy by addition of sodium bicarbonate antacid to oral vaccine formulation of live attenuated Salmonella secreting Brucella antigens</article-title>
          <source>Microbial Pathogenesis</source>
          <volume>138</volume>
          <year>2020</year>
          <object-id pub-id-type="publisher-id">103857</object-id>
        </element-citation>
      </ref>
      <ref id="bib47">
        <element-citation publication-type="journal" id="sref47"><person-group person-group-type="author"><name><surname>Hoebe</surname><given-names>K.</given-names></name><name><surname>Janssen</surname><given-names>E.</given-names></name><name><surname>Beutler</surname><given-names>B.</given-names></name></person-group><article-title>The interface between innate and adaptive immunity</article-title><source>Nature Immunology</source><volume>5</volume><year>2004</year><fpage>971</fpage><lpage>974</lpage><pub-id pub-id-type="pmid">15454919</pub-id>
</element-citation>
      </ref>
      <ref id="bib48">
        <element-citation publication-type="journal" id="sref48"><person-group person-group-type="author"><name><surname>Hoffmann</surname><given-names>E.M.</given-names></name><name><surname>Houle</surname><given-names>J.J.</given-names></name></person-group><article-title>Contradictory roles for antibody and complement in the interaction of Brucella abortus with its host</article-title><source>Critical Reviews in Microbiology</source><volume>21</volume><year>1995</year><fpage>153</fpage><lpage>163</lpage><pub-id pub-id-type="pmid">8845060</pub-id>
</element-citation>
      </ref>
      <ref id="bib49">
        <element-citation publication-type="journal" id="sref49"><person-group person-group-type="author"><name><surname>Horwell</surname><given-names>F.D.</given-names></name><name><surname>VAN Drimmelen</surname><given-names>G.G.</given-names></name></person-group><article-title>Brucella melitensis strain Rev I as a vaccine for cattle</article-title><source>Journal of the South African Veterinary Medical Association</source><volume>42</volume><year>1971</year><fpage>233</fpage><lpage>235</lpage><pub-id pub-id-type="pmid">5005602</pub-id>
</element-citation>
      </ref>
      <ref id="bib50">
        <element-citation publication-type="journal" id="sref50"><person-group person-group-type="author"><name><surname>Hsu</surname><given-names>S.K.</given-names></name><name><surname>Li</surname><given-names>C.Y.</given-names></name><name><surname>Lin</surname><given-names>I.L.</given-names></name><name><surname>Syue</surname><given-names>W.J.</given-names></name><name><surname>Chen</surname><given-names>Y.F.</given-names></name><name><surname>Cheng</surname><given-names>K.C.</given-names></name><etal/></person-group><article-title>Inflammation-related pyroptosis, a novel programmed cell death pathway, and its crosstalk with immune therapy in cancer treatment</article-title><source>Theranostics</source><volume>11</volume><year>2021</year><fpage>8813</fpage><lpage>8835</lpage><pub-id pub-id-type="pmid">34522213</pub-id>
</element-citation>
      </ref>
      <ref id="bib51">
        <element-citation publication-type="journal" id="sref51"><person-group person-group-type="author"><name><surname>Hsu</surname><given-names>H.</given-names></name><name><surname>Shu</surname><given-names>H.B.</given-names></name><name><surname>Pan</surname><given-names>M.G.</given-names></name><name><surname>Goeddel</surname><given-names>D.V.</given-names></name></person-group><article-title>TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways</article-title><source>Cell</source><volume>84</volume><year>1996</year><fpage>299</fpage><lpage>308</lpage><pub-id pub-id-type="pmid">8565075</pub-id>
</element-citation>
      </ref>
      <ref id="bib52">
        <element-citation publication-type="journal" id="sref52">
          <person-group person-group-type="author">
            <name>
              <surname>Hu</surname>
              <given-names>M.M.</given-names>
            </name>
            <name>
              <surname>Shu</surname>
              <given-names>H.B.</given-names>
            </name>
          </person-group>
          <article-title>Cytoplasmic mechanisms of recognition and defense of microbial nucleic acids</article-title>
          <source>Annual Review of Cell and Developmental Biology</source>
          <volume>34</volume>
          <year>2018</year>
          <fpage>357</fpage>
          <lpage>379</lpage>
        </element-citation>
      </ref>
      <ref id="bib53">
        <element-citation publication-type="journal" id="sref53">
          <person-group person-group-type="author">
            <name>
              <surname>Huy</surname>
              <given-names>T.X.N.</given-names>
            </name>
            <name>
              <surname>Nguyen</surname>
              <given-names>T.T.</given-names>
            </name>
            <name>
              <surname>Reyes</surname>
              <given-names>A.W.B.</given-names>
            </name>
            <name>
              <surname>Vu</surname>
              <given-names>S.H.</given-names>
            </name>
            <name>
              <surname>Min</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>H.J.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Immunization with a combination of four recombinant Brucella abortus proteins Omp16, Omp19, Omp28, and L7/L12 induces T helper 1 immune response against virulent B. Abortus 544 infection in BALB/c mice</article-title>
          <source>Frontiers in Veterinary Science</source>
          <volume>7</volume>
          <year>2020</year>
          <object-id pub-id-type="publisher-id">577026</object-id>
        </element-citation>
      </ref>
      <ref id="bib54">
        <element-citation publication-type="journal" id="sref54"><person-group person-group-type="author"><name><surname>Im</surname><given-names>Y.B.</given-names></name><name><surname>Jung</surname><given-names>M.</given-names></name><name><surname>Shin</surname><given-names>M.K.</given-names></name><name><surname>Kim</surname><given-names>S.</given-names></name><name><surname>Yoo</surname><given-names>H.S.</given-names></name></person-group><article-title>Expression of cytokine and apoptosis-related genes in bovine peripheral blood mononuclear cells stimulated with Brucella abortus recombinant proteins</article-title><source>Veterinary Research</source><volume>47</volume><year>2016</year><fpage>30</fpage><pub-id pub-id-type="pmid">26864657</pub-id>
</element-citation>
      </ref>
      <ref id="bib55">
        <element-citation publication-type="journal" id="sref55"><person-group person-group-type="author"><name><surname>Jakka</surname><given-names>P.</given-names></name><name><surname>Namani</surname><given-names>S.</given-names></name><name><surname>Murugan</surname><given-names>S.</given-names></name><name><surname>Rai</surname><given-names>N.</given-names></name><name><surname>Radhakrishnan</surname><given-names>G.</given-names></name></person-group><article-title>The Brucella effector protein TcpB induces degradation of inflammatory caspases and thereby subverts non-canonical inflammasome activation in macrophages</article-title><source>Journal of Biological Chemistry</source><volume>292</volume><year>2017</year><fpage>20613</fpage><lpage>20627</lpage><pub-id pub-id-type="pmid">29061850</pub-id>
</element-citation>
      </ref>
      <ref id="bib56">
        <element-citation publication-type="journal" id="sref56"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>H.</given-names></name><name><surname>O'Callaghan</surname><given-names>D.</given-names></name><name><surname>Ding</surname><given-names>J.B.</given-names></name></person-group><article-title>Brucellosis in China: History, progress and challenge</article-title><source>Infect Dis Poverty</source><volume>9</volume><year>2020</year><fpage>55</fpage><pub-id pub-id-type="pmid">32448394</pub-id>
</element-citation>
      </ref>
      <ref id="bib57">
        <element-citation publication-type="journal" id="sref57"><person-group person-group-type="author"><name><surname>Jiao</surname><given-names>H.</given-names></name><name><surname>Zhou</surname><given-names>Z.</given-names></name><name><surname>Li</surname><given-names>B.</given-names></name><name><surname>Xiao</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>M.</given-names></name><name><surname>Zeng</surname><given-names>H.</given-names></name><etal/></person-group><article-title>The mechanism of facultative intracellular parasitism of Brucella</article-title><source>International Journal of Molecular Sciences</source><volume>22</volume><year>2021</year><fpage>3673</fpage><pub-id pub-id-type="pmid">33916050</pub-id>
</element-citation>
      </ref>
      <ref id="bib58">
        <element-citation publication-type="journal" id="sref58"><person-group person-group-type="author"><name><surname>Karevan</surname><given-names>G.</given-names></name><name><surname>Ahmadi</surname><given-names>K.</given-names></name><name><surname>Taheri</surname><given-names>R.A.</given-names></name><name><surname>Fasihi-Ramandi</surname><given-names>M.</given-names></name></person-group><article-title>Immunogenicity of glycine nanoparticles containing a chimeric antigen as Brucella vaccine candidate</article-title><source>Clin Exp Vaccine Res</source><volume>10</volume><year>2021</year><fpage>35</fpage><lpage>43</lpage><pub-id pub-id-type="pmid">33628752</pub-id>
</element-citation>
      </ref>
      <ref id="bib59">
        <element-citation publication-type="journal" id="sref59">
          <person-group person-group-type="author">
            <name>
              <surname>Karmakar</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Minns</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Greenberg</surname>
              <given-names>E.N.</given-names>
            </name>
            <name>
              <surname>Diaz-Aponte</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Pestonjamasp</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Johnson</surname>
              <given-names>J.L.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>N-GSDMD trafficking to neutrophil organelles facilitates IL-1&#x3B2; release independently of plasma membrane pores and pyroptosis</article-title>
          <source>Nature Communications</source>
          <volume>11</volume>
          <year>2020</year>
          <fpage>2212</fpage>
        </element-citation>
      </ref>
      <ref id="bib60">
        <element-citation publication-type="journal" id="sref60"><person-group person-group-type="author"><name><surname>Ke</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>W.</given-names></name><name><surname>Chen</surname><given-names>Z.</given-names></name></person-group><article-title>Type IV secretion system of Brucella spp. and its effectors</article-title><source>Frontiers in Cellular and Infection Microbiology</source><volume>5</volume><year>2015</year><fpage>72</fpage><pub-id pub-id-type="pmid">26528442</pub-id>
</element-citation>
      </ref>
      <ref id="bib61">
        <element-citation publication-type="journal" id="sref61"><person-group person-group-type="author"><name><surname>Lacerda</surname><given-names>T.L.</given-names></name><name><surname>Salcedo</surname><given-names>S.P.</given-names></name><name><surname>Gorvel</surname><given-names>J.P.</given-names></name></person-group><article-title>Brucella T4SS: The VIP pass inside host cells</article-title><source>Current Opinion in Microbiology</source><volume>16</volume><year>2013</year><fpage>45</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">23318140</pub-id>
</element-citation>
      </ref>
      <ref id="bib62">
        <element-citation publication-type="journal" id="sref62">
          <person-group person-group-type="author">
            <name>
              <surname>Lacey</surname>
              <given-names>C.A.</given-names>
            </name>
            <name>
              <surname>Mitchell</surname>
              <given-names>W.J.</given-names>
            </name>
            <name>
              <surname>Dadelahi</surname>
              <given-names>A.S.</given-names>
            </name>
            <name>
              <surname>Skyberg</surname>
              <given-names>J.A.</given-names>
            </name>
          </person-group>
          <article-title>Caspase-1 and caspase-11 mediate pyroptosis, inflammation, and control of Brucella Joint infection</article-title>
          <source>Infection and Immunity</source>
          <volume>86, e00361-18</volume>
          <year>2018</year>
        </element-citation>
      </ref>
      <ref id="bib63">
        <element-citation publication-type="journal" id="sref63"><person-group person-group-type="author"><name><surname>Lapaque</surname><given-names>N.</given-names></name><name><surname>Muller</surname><given-names>A.</given-names></name><name><surname>Alexopoulou</surname><given-names>L.</given-names></name><name><surname>Howard</surname><given-names>J.C.</given-names></name><name><surname>Gorvel</surname><given-names>J.-P.</given-names></name></person-group><article-title>Brucella abortus induces Irgm3 and Irga6 expression via type-I IFN by a MyD88-dependent pathway, without the requirement of TLR2, TLR4, TLR5 and TLR9</article-title><source>Microbial Pathogenesis</source><volume>47</volume><year>2009</year><fpage>299</fpage><lpage>304</lpage><pub-id pub-id-type="pmid">19747534</pub-id>
</element-citation>
      </ref>
      <ref id="bib64">
        <element-citation publication-type="journal" id="sref64"><person-group person-group-type="author"><name><surname>Lapaque</surname><given-names>N.</given-names></name><name><surname>Takeuchi</surname><given-names>O.</given-names></name><name><surname>Corrales</surname><given-names>F.</given-names></name><name><surname>Akira</surname><given-names>S.</given-names></name><name><surname>Moriyon</surname><given-names>I.</given-names></name><name><surname>Howard</surname><given-names>J.C.</given-names></name><etal/></person-group><article-title>Differential inductions of TNF-alpha and IGTP, IIGP by structurally diverse classic and non-classic lipopolysaccharides</article-title><source>Cellular Microbiology</source><volume>8</volume><year>2006</year><fpage>401</fpage><lpage>413</lpage><pub-id pub-id-type="pmid">16469053</pub-id>
</element-citation>
      </ref>
      <ref id="bib65">
        <element-citation publication-type="journal" id="sref65"><person-group person-group-type="author"><name><surname>Lei</surname><given-names>C.Q.</given-names></name><name><surname>Wu</surname><given-names>X.</given-names></name><name><surname>Zhong</surname><given-names>X.</given-names></name><name><surname>Jiang</surname><given-names>L.</given-names></name><name><surname>Zhong</surname><given-names>B.</given-names></name><name><surname>Shu</surname><given-names>H.B.</given-names></name></person-group><article-title>USP19 inhibits TNF-&#x3B1;- and IL-1&#x3B2;-triggered NF-&#x3BA;B activation by deubiquitinating TAK1</article-title><source>The Journal of Immunology</source><volume>203</volume><year>2019</year><fpage>259</fpage><lpage>268</lpage><pub-id pub-id-type="pmid">31127032</pub-id>
</element-citation>
      </ref>
      <ref id="bib66">
        <element-citation publication-type="journal" id="sref66"><person-group person-group-type="author"><name><surname>Lei</surname><given-names>S.</given-names></name><name><surname>Zhong</surname><given-names>Z.</given-names></name><name><surname>Ke</surname><given-names>Y.</given-names></name><name><surname>Yang</surname><given-names>M.</given-names></name><name><surname>Xu</surname><given-names>X.</given-names></name><name><surname>Ren</surname><given-names>H.</given-names></name><etal/></person-group><article-title>Deletion of the small RNA chaperone protein hfq down regulates genes related to virulence and confers protection against wild-type Brucella challenge in mice</article-title><source>Frontiers in Microbiology</source><volume>6</volume><year>2015</year><fpage>1570</fpage><pub-id pub-id-type="pmid">26834720</pub-id>
</element-citation>
      </ref>
      <ref id="bib67">
        <element-citation publication-type="journal" id="sref67">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>The functions of polycomb group proteins in T cells</article-title>
          <source>Cell Insight</source>
          <volume>1</volume>
          <year>2022</year>
          <object-id pub-id-type="publisher-id">100048</object-id>
        </element-citation>
      </ref>
      <ref id="bib68">
        <element-citation publication-type="book" id="sref68">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <part-title><italic>Molecular mechanism inhibited the activation of cGAS-STING pathway by Brucella Omp25, RicA and BspB.</italic> Doctor</part-title>
          <year>2023</year>
          <publisher-name>College of Veterinary Medicine Northwest A&#xFF06;F University</publisher-name>
        </element-citation>
      </ref>
      <ref id="bib69">
        <element-citation publication-type="journal" id="sref69"><person-group person-group-type="author"><name><surname>Li</surname><given-names>W.</given-names></name><name><surname>Ke</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Yang</surname><given-names>M.</given-names></name><name><surname>Gao</surname><given-names>J.</given-names></name><name><surname>Zhan</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Brucella TIR-like protein TcpB/Btp1 specifically targets the host adaptor protein MAL/TIRAP to promote infection</article-title><source>Biochemical and Biophysical Research Communications</source><volume>477</volume><year>2016</year><fpage>509</fpage><lpage>514</lpage><pub-id pub-id-type="pmid">27311859</pub-id>
</element-citation>
      </ref>
      <ref id="bib70">
        <element-citation publication-type="journal" id="sref70">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Yin</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Zheng</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>X.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Brucella spp. Omp25 promotes proteasome-mediated cGAS degradation to attenuate IFN-&#x3B2; production</article-title>
          <source>Frontiers in Microbiology</source>
          <volume>12</volume>
          <year>2021</year>
          <object-id pub-id-type="publisher-id">702881</object-id>
        </element-citation>
      </ref>
      <ref id="bib71">
        <element-citation publication-type="journal" id="sref71"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Z.Q.</given-names></name><name><surname>Shi</surname><given-names>J.X.</given-names></name><name><surname>Fu</surname><given-names>W.D.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>Z.</given-names></name><etal/></person-group><article-title>A&#xA0;Brucella melitensis M5-90 wboA deletion strain is attenuated and enhances vaccine efficacy</article-title><source>Molecular Immunology</source><volume>66</volume><year>2015</year><fpage>276</fpage><lpage>283</lpage><pub-id pub-id-type="pmid">25899866</pub-id>
</element-citation>
      </ref>
      <ref id="bib72">
        <element-citation publication-type="journal" id="sref72"><person-group person-group-type="author"><name><surname>Li</surname><given-names>T.</given-names></name><name><surname>Tong</surname><given-names>Z.</given-names></name><name><surname>Huang</surname><given-names>M.</given-names></name><name><surname>Tang</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Chen</surname><given-names>C.</given-names></name></person-group><article-title>Brucella melitensis M5-90&#x394;bp26 as a potential live vaccine that allows for the distinction between natural infection and immunization</article-title><source>Canadian Journal of Microbiology</source><volume>63</volume><year>2017</year><fpage>719</fpage><lpage>729</lpage><pub-id pub-id-type="pmid">28482164</pub-id>
</element-citation>
      </ref>
      <ref id="bib73">
        <element-citation publication-type="journal" id="sref73"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Levine</surname><given-names>B.</given-names></name></person-group><article-title>Autosis and autophagic cell death: The dark side of autophagy</article-title><source>Cell Death &amp; Differentiation</source><volume>22</volume><year>2015</year><fpage>367</fpage><lpage>376</lpage><pub-id pub-id-type="pmid">25257169</pub-id>
</element-citation>
      </ref>
      <ref id="bib74">
        <element-citation publication-type="journal" id="sref74"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Sun</surname><given-names>Y.</given-names></name><name><surname>Ji</surname><given-names>X.</given-names></name><name><surname>Zhu</surname><given-names>L.</given-names></name><name><surname>Guo</surname><given-names>X.</given-names></name><etal/></person-group><article-title>Immune responses and protection induced by Brucella suis S2 bacterial ghosts in mice</article-title><source>Veterinary Immunology and Immunopathology</source><volume>166</volume><year>2015</year><fpage>138</fpage><lpage>144</lpage><pub-id pub-id-type="pmid">26022514</pub-id>
</element-citation>
      </ref>
      <ref id="bib75">
        <element-citation publication-type="journal" id="sref75"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Wang</surname><given-names>S.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>XI</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><etal/></person-group><article-title>Development and evaluation of in murine model, of an improved live-vaccine candidate against brucellosis from to Brucella melitensis vjbR deletion mutant</article-title><source>Microbial Pathogenesis</source><volume>124</volume><year>2018</year><fpage>250</fpage><lpage>257</lpage><pub-id pub-id-type="pmid">30149131</pub-id>
</element-citation>
      </ref>
      <ref id="bib76">
        <element-citation publication-type="journal" id="sref76"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Wang</surname><given-names>S.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Yang</surname><given-names>G.</given-names></name><name><surname>Yuan</surname><given-names>B.</given-names></name><name><surname>Huang</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Brucella abortus 2308&#x394;NodV&#x394;NodW double-mutant is highly attenuated and confers protection against wild-type challenge in BALB/c mice</article-title><source>Microbial Pathogenesis</source><volume>106</volume><year>2017</year><fpage>30</fpage><lpage>39</lpage><pub-id pub-id-type="pmid">28131952</pub-id>
</element-citation>
      </ref>
      <ref id="bib77">
        <element-citation publication-type="journal" id="sref77"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Z.Q.</given-names></name><name><surname>Zhang</surname><given-names>J.L.</given-names></name><name><surname>XI</surname><given-names>L.</given-names></name><name><surname>Yang</surname><given-names>G.L.</given-names></name><name><surname>Wang</surname><given-names>S.L.</given-names></name><name><surname>Zhang</surname><given-names>X.G.</given-names></name><etal/></person-group><article-title>Deletion of the transcriptional regulator GntR down regulated the expression of genes related to virulence and conferred protection against wild-type Brucella challenge in BALB/c mice</article-title><source>Molecular Immunology</source><volume>92</volume><year>2017</year><fpage>99</fpage><lpage>105</lpage><pub-id pub-id-type="pmid">29055858</pub-id>
</element-citation>
      </ref>
      <ref id="bib78">
        <element-citation publication-type="journal" id="sref78"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>K.E.</given-names></name><name><surname>Fu</surname><given-names>Q.</given-names></name><name><surname>Wang</surname><given-names>Z.</given-names></name><name><surname>Li</surname><given-names>T.</given-names></name><etal/></person-group><article-title>Brucella melitensis 16M&#x394;TcfSR as a potential live vaccine allows for the differentiation between natural and vaccinated infection</article-title><source>Experimental and Therapeutic Medicine</source><volume>10</volume><year>2015</year><fpage>1182</fpage><lpage>1188</lpage><pub-id pub-id-type="pmid">26622461</pub-id>
</element-citation>
      </ref>
      <ref id="bib79">
        <element-citation publication-type="journal" id="sref79"><person-group person-group-type="author"><name><surname>Luo</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Wu</surname><given-names>X.</given-names></name><name><surname>Yang</surname><given-names>X.</given-names></name><name><surname>Han</surname><given-names>C.</given-names></name><name><surname>Wang</surname><given-names>Z.</given-names></name><etal/></person-group><article-title>Brucella downregulates tumor necrosis factor-&#x3B1; to promote intracellular survival via Omp25 regulation of different MicroRNAs in porcine and murine macrophages</article-title><source>Frontiers in Immunology</source><volume>8</volume><year>2017</year><fpage>2013</fpage><pub-id pub-id-type="pmid">29387067</pub-id>
</element-citation>
      </ref>
      <ref id="bib80">
        <element-citation publication-type="journal" id="sref80"><person-group person-group-type="author"><name><surname>Marchi</surname><given-names>S.</given-names></name><name><surname>Patergnani</surname><given-names>S.</given-names></name><name><surname>Missiroli</surname><given-names>S.</given-names></name><name><surname>Morciano</surname><given-names>G.</given-names></name><name><surname>Rimessi</surname><given-names>A.</given-names></name><name><surname>Wieckowski</surname><given-names>M.R.</given-names></name><etal/></person-group><article-title>Mitochondrial and endoplasmic reticulum calcium homeostasis and cell death</article-title><source>Cell Calcium</source><volume>69</volume><year>2018</year><fpage>62</fpage><lpage>72</lpage><pub-id pub-id-type="pmid">28515000</pub-id>
</element-citation>
      </ref>
      <ref id="bib81">
        <element-citation publication-type="journal" id="sref81"><person-group person-group-type="author"><name><surname>Marim</surname><given-names>F.M.</given-names></name><name><surname>Franco</surname><given-names>M.M.C.</given-names></name><name><surname>Gomes</surname><given-names>M.T.R.</given-names></name><name><surname>Miraglia</surname><given-names>M.C.</given-names></name><name><surname>Giambartolomei</surname><given-names>G.H.</given-names></name><name><surname>Oliveira</surname><given-names>S.C.</given-names></name></person-group><article-title>The role of NLRP3 and AIM2 in inflammasome activation during Brucella abortus infection</article-title><source>Seminars in Immunopathology</source><volume>39</volume><year>2017</year><fpage>215</fpage><lpage>223</lpage><pub-id pub-id-type="pmid">27405866</pub-id>
</element-citation>
      </ref>
      <ref id="bib82">
        <element-citation publication-type="journal" id="sref82"><person-group person-group-type="author"><name><surname>Martirosyan</surname><given-names>A.</given-names></name><name><surname>Gorvel</surname><given-names>J.P.</given-names></name></person-group><article-title>Brucella evasion of adaptive immunity</article-title><source>Future Microbiology</source><volume>8</volume><year>2013</year><fpage>147</fpage><lpage>154</lpage><pub-id pub-id-type="pmid">23374122</pub-id>
</element-citation>
      </ref>
      <ref id="bib83">
        <element-citation publication-type="journal" id="sref83"><person-group person-group-type="author"><name><surname>Martirosyan</surname><given-names>A.</given-names></name><name><surname>Moreno</surname><given-names>E.</given-names></name><name><surname>Gorvel</surname><given-names>J.P.</given-names></name></person-group><article-title>An evolutionary strategy for a stealthy intracellular Brucella pathogen</article-title><source>Immunological Reviews</source><volume>240</volume><year>2011</year><fpage>211</fpage><lpage>234</lpage><pub-id pub-id-type="pmid">21349096</pub-id>
</element-citation>
      </ref>
      <ref id="bib84">
        <element-citation publication-type="journal" id="sref84"><person-group person-group-type="author"><name><surname>Masjedian Jezi</surname><given-names>F.</given-names></name><name><surname>Razavi</surname><given-names>S.</given-names></name><name><surname>Mirnejad</surname><given-names>R.</given-names></name><name><surname>Zamani</surname><given-names>K.</given-names></name></person-group><article-title>Immunogenic and protective antigens of Brucella as vaccine candidates</article-title><source>Comparative Immunology, Microbiology and Infectious Diseases</source><volume>65</volume><year>2019</year><fpage>29</fpage><lpage>36</lpage><pub-id pub-id-type="pmid">31300122</pub-id>
</element-citation>
      </ref>
      <ref id="bib85">
        <element-citation publication-type="journal" id="sref85">
          <person-group person-group-type="author">
            <name>
              <surname>Meizlish</surname>
              <given-names>M.L.</given-names>
            </name>
            <name>
              <surname>Franklin</surname>
              <given-names>R.A.</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Medzhitov</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Tissue homeostasis and inflammation</article-title>
          <source>Annual Review of Immunology</source>
          <volume>39</volume>
          <year>2021</year>
          <fpage>557</fpage>
          <lpage>581</lpage>
        </element-citation>
      </ref>
      <ref id="bib86">
        <element-citation publication-type="journal" id="sref86">
          <person-group person-group-type="author">
            <name>
              <surname>Mohammadi</surname>
              <given-names>Y.</given-names>
            </name>
          </person-group>
          <article-title>Evaluation of the immunogenicity and efficacy of a chimeric OMP25-OMP31 antigen in BALB/c mice</article-title>
          <source>Veterinary Medical Science</source>
          <volume>7</volume>
          <year>2021</year>
          <fpage>2008</fpage>
          <lpage>2014</lpage>
        </element-citation>
      </ref>
      <ref id="bib87">
        <element-citation publication-type="journal" id="sref87">
          <person-group person-group-type="author">
            <name>
              <surname>Mohammadi</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Golchin</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>High protection of mice against Brucella abortus by oral immunization with recombinant probiotic Lactobacillus casei vector vaccine, expressing the outer membrane protein OMP19 of Brucella species</article-title>
          <source>Comparative Immunology, Microbiology and Infectious Diseases</source>
          <volume>70</volume>
          <year>2020</year>
          <object-id pub-id-type="publisher-id">101470</object-id>
        </element-citation>
      </ref>
      <ref id="bib88">
        <element-citation publication-type="journal" id="sref88"><person-group person-group-type="author"><name><surname>Moreno</surname><given-names>E.</given-names></name></person-group><article-title>Retrospective and prospective perspectives on zoonotic brucellosis</article-title><source>Frontiers in Microbiology</source><volume>5</volume><year>2014</year><fpage>213</fpage><pub-id pub-id-type="pmid">24860561</pub-id>
</element-citation>
      </ref>
      <ref id="bib89">
        <element-citation publication-type="journal" id="sref89"><person-group person-group-type="author"><name><surname>Moyle</surname><given-names>P.M.</given-names></name><name><surname>Toth</surname><given-names>I.</given-names></name></person-group><article-title>Modern subunit vaccines: Development, components, and research opportunities</article-title><source>ChemMedChem</source><volume>8</volume><year>2013</year><fpage>360</fpage><lpage>376</lpage><pub-id pub-id-type="pmid">23316023</pub-id>
</element-citation>
      </ref>
      <ref id="bib90">
        <element-citation publication-type="journal" id="sref90"><person-group person-group-type="author"><name><surname>Netea</surname><given-names>M.G.</given-names></name><name><surname>Schlitzer</surname><given-names>A.</given-names></name><name><surname>Placek</surname><given-names>K.</given-names></name><name><surname>Joosten</surname><given-names>L.A.B.</given-names></name><name><surname>Schultze</surname><given-names>J.L.</given-names></name></person-group><article-title>Innate and adaptive immune memory: An evolutionary continuum in the host's response to pathogens</article-title><source>Cell Host &amp; Microbe</source><volume>25</volume><year>2019</year><fpage>13</fpage><lpage>26</lpage><pub-id pub-id-type="pmid">30629914</pub-id>
</element-citation>
      </ref>
      <ref id="bib91">
        <element-citation publication-type="journal" id="sref91"><person-group person-group-type="author"><name><surname>O'Neill</surname><given-names>L.A.</given-names></name><name><surname>Dunne</surname><given-names>A.</given-names></name><name><surname>Edjeback</surname><given-names>M.</given-names></name><name><surname>Gray</surname><given-names>P.</given-names></name><name><surname>Jefferies</surname><given-names>C.</given-names></name><name><surname>Wietek</surname><given-names>C.</given-names></name></person-group><article-title>Mal and MyD88: Adapter proteins involved in signal transduction by toll-like receptors</article-title><source>Journal of Endotoxin Research</source><volume>9</volume><year>2003</year><fpage>55</fpage><lpage>59</lpage><pub-id pub-id-type="pmid">12691620</pub-id>
</element-citation>
      </ref>
      <ref id="bib92">
        <element-citation publication-type="journal" id="sref92">
          <person-group person-group-type="author">
            <name>
              <surname>Pappas</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>The changing Brucella ecology: Novel reservoirs, new threats</article-title>
          <source>International Journal of Antimicrobial Agents</source>
          <volume>36</volume>
          <issue>Suppl 1</issue>
          <year>2010</year>
          <fpage>S8</fpage>
          <lpage>S11</lpage>
        </element-citation>
      </ref>
      <ref id="bib93">
        <element-citation publication-type="journal" id="sref93"><person-group person-group-type="author"><name><surname>Pappas</surname><given-names>G.</given-names></name><name><surname>Papadimitriou</surname><given-names>P.</given-names></name><name><surname>Akritidis</surname><given-names>N.</given-names></name><name><surname>Christou</surname><given-names>L.</given-names></name><name><surname>Tsianos</surname><given-names>E.V.</given-names></name></person-group><article-title>The new global map of human brucellosis</article-title><source>The Lancet Infectious Diseases</source><volume>6</volume><year>2006</year><fpage>91</fpage><lpage>99</lpage><pub-id pub-id-type="pmid">16439329</pub-id>
</element-citation>
      </ref>
      <ref id="bib94">
        <element-citation publication-type="journal" id="sref94"><person-group person-group-type="author"><name><surname>Pascual</surname><given-names>D.W.</given-names></name><name><surname>Yang</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Goodwin</surname><given-names>Z.</given-names></name><name><surname>Hoffman</surname><given-names>C.</given-names></name><name><surname>Clapp</surname><given-names>B.</given-names></name></person-group><article-title>Alternative strategies for vaccination to brucellosis</article-title><source>Microbes and Infection</source><volume>20</volume><year>2018</year><fpage>599</fpage><lpage>605</lpage><pub-id pub-id-type="pmid">29287984</pub-id>
</element-citation>
      </ref>
      <ref id="bib95">
        <element-citation publication-type="journal" id="sref95"><person-group person-group-type="author"><name><surname>Pasquali</surname><given-names>P.</given-names></name><name><surname>Thornton</surname><given-names>A.M.</given-names></name><name><surname>Vendetti</surname><given-names>S.</given-names></name><name><surname>Pistoia</surname><given-names>C.</given-names></name><name><surname>Petrucci</surname><given-names>P.</given-names></name><name><surname>Tarantino</surname><given-names>M.</given-names></name><etal/></person-group><article-title>CD4+CD25+ T regulatory cells limit effector T cells and favor the progression of brucellosis in BALB/c mice</article-title><source>Microbes and Infection</source><volume>12</volume><year>2010</year><fpage>3</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">19772948</pub-id>
</element-citation>
      </ref>
      <ref id="bib96">
        <element-citation publication-type="journal" id="sref96"><person-group person-group-type="author"><name><surname>Pasquevich</surname><given-names>K.A.</given-names></name><name><surname>Carabajal</surname><given-names>M.V.</given-names></name><name><surname>Guaimas</surname><given-names>F.F.</given-names></name><name><surname>Bruno</surname><given-names>L.</given-names></name><name><surname>Roset</surname><given-names>M.S.</given-names></name><name><surname>Coria</surname><given-names>L.M.</given-names></name><etal/></person-group><article-title>Omp19 enables Brucella abortus to evade the antimicrobial activity from host's proteolytic defense system</article-title><source>Frontiers in Immunology</source><volume>10</volume><year>2019</year><fpage>1436</fpage><pub-id pub-id-type="pmid">31297115</pub-id>
</element-citation>
      </ref>
      <ref id="bib97">
        <element-citation publication-type="journal" id="sref97"><person-group person-group-type="author"><name><surname>Perkins</surname><given-names>S.D.</given-names></name><name><surname>Smither</surname><given-names>S.J.</given-names></name><name><surname>Atkins</surname><given-names>H.S.</given-names></name></person-group><article-title>Towards a Brucella vaccine for humans</article-title><source>FEMS Microbiology Reviews</source><volume>34</volume><year>2010</year><fpage>379</fpage><lpage>394</lpage><pub-id pub-id-type="pmid">20180858</pub-id>
</element-citation>
      </ref>
      <ref id="bib98">
        <element-citation publication-type="journal" id="sref98"><person-group person-group-type="author"><name><surname>Radhakrishnan</surname><given-names>G.K.</given-names></name><name><surname>Splitter</surname><given-names>G.A.</given-names></name></person-group><article-title>Biochemical and functional analysis of TIR domain containing protein from Brucella melitensis</article-title><source>Biochemical and Biophysical Research Communications</source><volume>397</volume><year>2010</year><fpage>59</fpage><lpage>63</lpage><pub-id pub-id-type="pmid">20471373</pub-id>
</element-citation>
      </ref>
      <ref id="bib99">
        <element-citation publication-type="journal" id="sref99">
          <person-group person-group-type="author">
            <name>
              <surname>Roop</surname>
              <given-names>R.M.2N.D.</given-names>
            </name>
            <name>
              <surname>Barton</surname>
              <given-names>I.S.</given-names>
            </name>
            <name>
              <surname>Hopersberger</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Martin</surname>
              <given-names>D.W.</given-names>
            </name>
          </person-group>
          <article-title>Uncovering the hidden credentials of Brucella virulence</article-title>
          <source>Microbiology and Molecular Biology Reviews</source>
          <volume>85, e00021-19</volume>
          <year>2021</year>
        </element-citation>
      </ref>
      <ref id="bib100">
        <element-citation publication-type="journal" id="sref100"><person-group person-group-type="author"><name><surname>Ruf</surname><given-names>B.</given-names></name><name><surname>Greten</surname><given-names>T.F.</given-names></name><name><surname>Korangy</surname><given-names>F.</given-names></name></person-group><article-title>Innate lymphoid cells and innate-like T cells in cancer - at the crossroads of innate and adaptive immunity</article-title><source>Nature Reviews Cancer</source><volume>23</volume><year>2023</year><fpage>351</fpage><lpage>371</lpage><pub-id pub-id-type="pmid">37081117</pub-id>
</element-citation>
      </ref>
      <ref id="bib101">
        <element-citation publication-type="journal" id="sref101"><person-group person-group-type="author"><name><surname>S&#xE1;ez</surname><given-names>D.</given-names></name><name><surname>Fern&#xE1;NDEZ</surname><given-names>P.</given-names></name><name><surname>Rivera</surname><given-names>A.</given-names></name><name><surname>Andrews</surname><given-names>E.</given-names></name><name><surname>O&#xF1;ATE</surname><given-names>A.</given-names></name></person-group><article-title>Oral immunization of mice with recombinant Lactococcus lactis expressing Cu,Zn superoxide dismutase of Brucella abortus triggers protective immunity</article-title><source>Vaccine</source><volume>30</volume><year>2012</year><fpage>1283</fpage><lpage>1290</lpage><pub-id pub-id-type="pmid">22222868</pub-id>
</element-citation>
      </ref>
      <ref id="bib102">
        <element-citation publication-type="journal" id="sref102"><person-group person-group-type="author"><name><surname>Salcedo</surname><given-names>S.P.</given-names></name><name><surname>Marchesini</surname><given-names>M.I.</given-names></name><name><surname>Degos</surname><given-names>C.</given-names></name><name><surname>Terwagne</surname><given-names>M.</given-names></name><name><surname>VON Bargen</surname><given-names>K.</given-names></name><name><surname>Lepidi</surname><given-names>H.</given-names></name><etal/></person-group><article-title>BtpB, a novel Brucella TIR-containing effector protein with immune modulatory functions</article-title><source>Frontiers in Cellular and Infection Microbiology</source><volume>3</volume><year>2013</year><fpage>28</fpage><pub-id pub-id-type="pmid">23847770</pub-id>
</element-citation>
      </ref>
      <ref id="bib103">
        <element-citation publication-type="journal" id="sref103"><person-group person-group-type="author"><name><surname>Salcedo</surname><given-names>S.P.</given-names></name><name><surname>Marchesini</surname><given-names>M.I.</given-names></name><name><surname>Lelouard</surname><given-names>H.</given-names></name><name><surname>Fugier</surname><given-names>E.</given-names></name><name><surname>Jolly</surname><given-names>G.</given-names></name><name><surname>Balor</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Brucella control of dendritic cell maturation is dependent on the TIR-containing protein Btp1</article-title><source>PLoS Pathogens</source><volume>4</volume><year>2008</year><fpage>e21</fpage><pub-id pub-id-type="pmid">18266466</pub-id>
</element-citation>
      </ref>
      <ref id="bib104">
        <element-citation publication-type="journal" id="sref104"><person-group person-group-type="author"><name><surname>Sancho</surname><given-names>P.</given-names></name><name><surname>Tejedor</surname><given-names>C.</given-names></name><name><surname>Sidhu-Mu&#xF1;OZ</surname><given-names>R.S.</given-names></name><name><surname>Fern&#xE1;NDEZ-Lago</surname><given-names>L.</given-names></name><name><surname>Vizca&#xED;NO</surname><given-names>N.</given-names></name></person-group><article-title>Evaluation in mice of Brucella ovis attenuated mutants for use as live vaccines against B. ovis infection</article-title><source>Veterinary Research</source><volume>45</volume><year>2014</year><fpage>61</fpage><pub-id pub-id-type="pmid">24898325</pub-id>
</element-citation>
      </ref>
      <ref id="bib105">
        <element-citation publication-type="journal" id="sref105"><person-group person-group-type="author"><name><surname>Saqib</surname><given-names>U.</given-names></name><name><surname>Baig</surname><given-names>M.S.</given-names></name></person-group><article-title>Scaffolding role of TcpB in disrupting TLR4-Mal interactions: Three to tango</article-title><source>Journal of Cellular Biochemistry</source><volume>120</volume><year>2019</year><fpage>3455</fpage><lpage>3458</lpage><pub-id pub-id-type="pmid">30242887</pub-id>
</element-citation>
      </ref>
      <ref id="bib106">
        <element-citation publication-type="journal" id="sref106">
          <person-group person-group-type="author">
            <name>
              <surname>Sedzicki</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Tschon</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Low</surname>
              <given-names>S.H.</given-names>
            </name>
            <name>
              <surname>Willemart</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Goldie</surname>
              <given-names>K.N.</given-names>
            </name>
            <name>
              <surname>Letesson</surname>
              <given-names>J.J.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>3D correlative electron microscopy reveals continuity of Brucella-containing vacuoles with the endoplasmic reticulum</article-title>
          <source>Journal of Cell Science</source>
          <volume>131, jcs210799</volume>
          <year>2018</year>
        </element-citation>
      </ref>
      <ref id="bib107">
        <element-citation publication-type="journal" id="sref107"><person-group person-group-type="author"><name><surname>Senevirathne</surname><given-names>A.</given-names></name><name><surname>Hewawaduge</surname><given-names>C.</given-names></name><name><surname>Lee</surname><given-names>J.H.</given-names></name></person-group><article-title>Live vaccine consisting of attenuated Salmonella secreting and delivering Brucella ribosomal protein L7/L12 induces humoral and cellular immune responses and protects mice against virulent Brucella abortus 544 challenge</article-title><source>Veterinary Research</source><volume>51</volume><year>2020</year><fpage>6</fpage><pub-id pub-id-type="pmid">31973749</pub-id>
</element-citation>
      </ref>
      <ref id="bib108">
        <element-citation publication-type="journal" id="sref108"><person-group person-group-type="author"><name><surname>Sengupta</surname><given-names>D.</given-names></name><name><surname>Koblansky</surname><given-names>A.</given-names></name><name><surname>Gaines</surname><given-names>J.</given-names></name><name><surname>Brown</surname><given-names>T.</given-names></name><name><surname>West</surname><given-names>A.P.</given-names></name><name><surname>Zhang</surname><given-names>D.</given-names></name><etal/></person-group><article-title>Subversion of innate immune responses by Brucella through the targeted degradation of the TLR signaling adapter, MAL</article-title><source>The Journal of Immunology</source><volume>184</volume><year>2010</year><fpage>956</fpage><lpage>964</lpage><pub-id pub-id-type="pmid">20018612</pub-id>
</element-citation>
      </ref>
      <ref id="bib109">
        <element-citation publication-type="journal" id="sref109">
          <person-group person-group-type="author">
            <name>
              <surname>Shao</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Qi</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>A&#xA0;role for Hes1 in constraining germinal center B cell formation</article-title>
          <source>Cell Insight</source>
          <volume>2</volume>
          <year>2023</year>
          <object-id pub-id-type="publisher-id">100078</object-id>
        </element-citation>
      </ref>
      <ref id="bib110">
        <element-citation publication-type="journal" id="sref110"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>H.</given-names></name><name><surname>Gao</surname><given-names>Y.</given-names></name><name><surname>Dong</surname><given-names>Z.</given-names></name><name><surname>Yang</surname><given-names>J.</given-names></name><name><surname>Gao</surname><given-names>R.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><etal/></person-group><article-title>GSDMD-mediated cardiomyocyte pyroptosis promotes myocardial I/R injury</article-title><source>Circulation Research</source><volume>129</volume><year>2021</year><fpage>383</fpage><lpage>396</lpage><pub-id pub-id-type="pmid">34015941</pub-id>
</element-citation>
      </ref>
      <ref id="bib111">
        <element-citation publication-type="journal" id="sref111">
          <person-group person-group-type="author">
            <name>
              <surname>Shim</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Soh</surname>
              <given-names>S.H.</given-names>
            </name>
            <name>
              <surname>Im</surname>
              <given-names>Y.B.</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>H.E.</given-names>
            </name>
            <name>
              <surname>Cho</surname>
              <given-names>C.S.</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>S.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Elicitation of Th1/Th2 related responses in mice by chitosan nanoparticles loaded with Brucella abortus malate dehydrogenase, outer membrane proteins 10 and 19</article-title>
          <source>Int J Med Microbiol</source>
          <volume>310</volume>
          <year>2020</year>
          <object-id pub-id-type="publisher-id">151362</object-id>
        </element-citation>
      </ref>
      <ref id="bib112">
        <element-citation publication-type="journal" id="sref112"><person-group person-group-type="author"><name><surname>Shojaei</surname><given-names>M.</given-names></name><name><surname>Tahmoorespur</surname><given-names>M.</given-names></name><name><surname>Soltani</surname><given-names>M.</given-names></name><name><surname>Sekhavati</surname><given-names>M.H.</given-names></name></person-group><article-title>Immunogenicity evaluation of plasmids encoding Brucella melitensis Omp25 and Omp31 antigens in BALB/c mice</article-title><source>Iran J Basic Med Sci</source><volume>21</volume><year>2018</year><fpage>957</fpage><lpage>964</lpage><pub-id pub-id-type="pmid">30524697</pub-id>
</element-citation>
      </ref>
      <ref id="bib113">
        <element-citation publication-type="journal" id="sref113">
          <person-group person-group-type="author">
            <name>
              <surname>Shu</surname>
              <given-names>H.B.</given-names>
            </name>
            <name>
              <surname>Takeuchi</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Goeddel</surname>
              <given-names>D.V.</given-names>
            </name>
          </person-group>
          <article-title>The tumor necrosis factor receptor 2 signal transducers TRAF2 and c-IAP1 are components of the tumor necrosis factor receptor 1 signaling complex</article-title>
          <source>Proceedings of the National Academy of Sciences of the U S A</source>
          <volume>93</volume>
          <year>1996</year>
          <fpage>13973</fpage>
          <lpage>13978</lpage>
        </element-citation>
      </ref>
      <ref id="bib114">
        <element-citation publication-type="journal" id="sref114"><person-group person-group-type="author"><name><surname>Sieira</surname><given-names>R.</given-names></name><name><surname>Comerci</surname><given-names>D.J.</given-names></name><name><surname>S&#xE1;NCHEZ</surname><given-names>D.O.</given-names></name><name><surname>Ugalde</surname><given-names>R.A.</given-names></name></person-group><article-title>A&#xA0;homologue of an operon required for DNA transfer in Agrobacterium is required in Brucella abortus for virulence and intracellular multiplication</article-title><source>Journal of Bacteriology</source><volume>182</volume><year>2000</year><fpage>4849</fpage><lpage>4855</lpage><pub-id pub-id-type="pmid">10940027</pub-id>
</element-citation>
      </ref>
      <ref id="bib115">
        <element-citation publication-type="journal" id="sref115"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>D.</given-names></name><name><surname>Somani</surname><given-names>V.K.</given-names></name><name><surname>Aggarwal</surname><given-names>S.</given-names></name><name><surname>Bhatnagar</surname><given-names>R.</given-names></name></person-group><article-title>PLGA (85:15) nanoparticle based delivery of rL7/L12 ribosomal protein in mice protects against Brucella abortus 544 infection: A promising alternate to traditional adjuvants</article-title><source>Molecular Immunology</source><volume>68</volume><year>2015</year><fpage>272</fpage><lpage>279</lpage><pub-id pub-id-type="pmid">26442664</pub-id>
</element-citation>
      </ref>
      <ref id="bib116">
        <element-citation publication-type="journal" id="sref116"><person-group person-group-type="author"><name><surname>Snyder</surname><given-names>G.A.</given-names></name><name><surname>Deredge</surname><given-names>D.</given-names></name><name><surname>Waldhuber</surname><given-names>A.</given-names></name><name><surname>Fresquez</surname><given-names>T.</given-names></name><name><surname>Wilkins</surname><given-names>D.Z.</given-names></name><name><surname>Smith</surname><given-names>P.T.</given-names></name><etal/></person-group><article-title>Crystal structures of the Toll/Interleukin-1 receptor (TIR) domains from the Brucella protein TcpB and host adaptor TIRAP reveal mechanisms of molecular mimicry</article-title><source>Journal of Biological Chemistry</source><volume>289</volume><year>2014</year><fpage>669</fpage><lpage>679</lpage><pub-id pub-id-type="pmid">24275656</pub-id>
</element-citation>
      </ref>
      <ref id="bib117">
        <element-citation publication-type="journal" id="sref117"><person-group person-group-type="author"><name><surname>Starr</surname><given-names>T.</given-names></name><name><surname>Child</surname><given-names>R.</given-names></name><name><surname>Wehrly</surname><given-names>T.D.</given-names></name><name><surname>Hansen</surname><given-names>B.</given-names></name><name><surname>Hwang</surname><given-names>S.</given-names></name><name><surname>L&#xF3;PEZ-Otin</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Selective subversion of autophagy complexes facilitates completion of the Brucella intracellular cycle</article-title><source>Cell Host &amp; Microbe</source><volume>11</volume><year>2012</year><fpage>33</fpage><lpage>45</lpage><pub-id pub-id-type="pmid">22264511</pub-id>
</element-citation>
      </ref>
      <ref id="bib118">
        <element-citation publication-type="journal" id="sref118"><person-group person-group-type="author"><name><surname>Starr</surname><given-names>T.</given-names></name><name><surname>Ng</surname><given-names>T.W.</given-names></name><name><surname>Wehrly</surname><given-names>T.D.</given-names></name><name><surname>Knodler</surname><given-names>L.A.</given-names></name><name><surname>Celli</surname><given-names>J.</given-names></name></person-group><article-title>Brucella intracellular replication requires trafficking through the late endosomal/lysosomal compartment</article-title><source>Traffic</source><volume>9</volume><year>2008</year><fpage>678</fpage><lpage>694</lpage><pub-id pub-id-type="pmid">18266913</pub-id>
</element-citation>
      </ref>
      <ref id="bib119">
        <element-citation publication-type="journal" id="sref119">
          <person-group person-group-type="author">
            <name>
              <surname>Taguchi</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Imaoka</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Kataoka</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Uda</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Nakatsu</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Horii-Okazaki</surname>
              <given-names>S.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Yip1A, a novel host factor for the activation of the IRE1 pathway of the unfolded protein response during Brucella infection</article-title>
          <source>PLoS Pathogens</source>
          <volume>11</volume>
          <year>2015</year>
          <object-id pub-id-type="publisher-id">e1004747</object-id>
        </element-citation>
      </ref>
      <ref id="bib120">
        <element-citation publication-type="journal" id="sref120"><person-group person-group-type="author"><name><surname>Truong</surname><given-names>Q.L.</given-names></name><name><surname>Cho</surname><given-names>Y.</given-names></name><name><surname>Kim</surname><given-names>K.</given-names></name><name><surname>Park</surname><given-names>B.K.</given-names></name><name><surname>Hahn</surname><given-names>T.W.</given-names></name></person-group><article-title>Booster vaccination with safe, modified, live-attenuated mutants of Brucella abortus strain RB51 vaccine confers protective immunity against virulent strains of B. abortus and Brucella canis in BALB/c mice</article-title><source>Microbiology (Reading)</source><volume>161</volume><year>2015</year><fpage>2137</fpage><lpage>2148</lpage><pub-id pub-id-type="pmid">26341622</pub-id>
</element-citation>
      </ref>
      <ref id="bib121">
        <element-citation publication-type="journal" id="sref121"><person-group person-group-type="author"><name><surname>Truong</surname><given-names>Q.L.</given-names></name><name><surname>Cho</surname><given-names>Y.</given-names></name><name><surname>Park</surname><given-names>S.</given-names></name><name><surname>Kim</surname><given-names>K.</given-names></name><name><surname>Hahn</surname><given-names>T.W.</given-names></name></person-group><article-title>Brucella abortus&#x394;cydC&#x394;cydD and &#x394;cydC&#x394;purD double-mutants are highly attenuated and confer long-term protective immunity against virulent Brucella abortus</article-title><source>Vaccine</source><volume>34</volume><year>2016</year><fpage>237</fpage><lpage>244</lpage><pub-id pub-id-type="pmid">26616550</pub-id>
</element-citation>
      </ref>
      <ref id="bib122">
        <element-citation publication-type="journal" id="sref122">
          <person-group person-group-type="author">
            <name>
              <surname>Tupik</surname>
              <given-names>J.D.</given-names>
            </name>
            <name>
              <surname>Coutermarsh-Ott</surname>
              <given-names>S.L.</given-names>
            </name>
            <name>
              <surname>Benton</surname>
              <given-names>A.H.</given-names>
            </name>
            <name>
              <surname>King</surname>
              <given-names>K.A.</given-names>
            </name>
            <name>
              <surname>Kiryluk</surname>
              <given-names>H.D.</given-names>
            </name>
            <name>
              <surname>Caswell</surname>
              <given-names>C.C.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>ASC-mediated inflammation and pyroptosis attenuates Brucella abortus pathogenesis following the recognition of gDNA</article-title>
          <source>Pathogens</source>
          <volume>9, 1008</volume>
          <year>2020</year>
        </element-citation>
      </ref>
      <ref id="bib123">
        <element-citation publication-type="journal" id="sref123"><person-group person-group-type="author"><name><surname>Velikovsky</surname><given-names>C.A.</given-names></name><name><surname>Cassataro</surname><given-names>J.</given-names></name><name><surname>Sanchez</surname><given-names>M.</given-names></name><name><surname>Fossati</surname><given-names>C.A.</given-names></name><name><surname>Fainboim</surname><given-names>L.</given-names></name><name><surname>Spitz</surname><given-names>M.</given-names></name></person-group><article-title>Single-shot plasmid DNA intrasplenic immunization for the production of monoclonal antibodies. Persistent expression of DNA</article-title><source>Journal of Immunological Methods</source><volume>244</volume><year>2000</year><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">11033013</pub-id>
</element-citation>
      </ref>
      <ref id="bib124">
        <element-citation publication-type="journal" id="sref124"><person-group person-group-type="author"><name><surname>Vellinga</surname><given-names>J.</given-names></name><name><surname>Smith</surname><given-names>J.P.</given-names></name><name><surname>Lipiec</surname><given-names>A.</given-names></name><name><surname>Majhen</surname><given-names>D.</given-names></name><name><surname>Lemckert</surname><given-names>A.</given-names></name><name><surname>VAN Ooij</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Challenges in manufacturing adenoviral vectors for global vaccine product deployment</article-title><source>Human Gene Therapy</source><volume>25</volume><year>2014</year><fpage>318</fpage><lpage>327</lpage><pub-id pub-id-type="pmid">24593243</pub-id>
</element-citation>
      </ref>
      <ref id="bib125">
        <element-citation publication-type="journal" id="sref125"><person-group person-group-type="author"><name><surname>Verger</surname><given-names>J.M.</given-names></name><name><surname>Grayon</surname><given-names>M.</given-names></name><name><surname>Zundel</surname><given-names>E.</given-names></name><name><surname>Lechopier</surname><given-names>P.</given-names></name><name><surname>Olivier-Bernardin</surname><given-names>V.</given-names></name></person-group><article-title>Comparison of the efficacy of Brucella suis strain 2 and Brucella melitensis Rev. 1 live vaccines against a Brucella melitensis experimental infection in pregnant ewes</article-title><source>Vaccine</source><volume>13</volume><year>1995</year><fpage>191</fpage><lpage>196</lpage><pub-id pub-id-type="pmid">7625115</pub-id>
</element-citation>
      </ref>
      <ref id="bib126">
        <element-citation publication-type="journal" id="sref126"><person-group person-group-type="author"><name><surname>Vershilova</surname><given-names>P.A.</given-names></name></person-group><article-title>The use of live vaccine for vaccination of human beings against brucellosis in the USSR</article-title><source>Bulletin of the World Health Organization</source><volume>24</volume><year>1961</year><fpage>85</fpage><lpage>89</lpage><pub-id pub-id-type="pmid">13780996</pub-id>
</element-citation>
      </ref>
      <ref id="bib127">
        <element-citation publication-type="journal" id="sref127"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Lin</surname><given-names>P.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Xiang</surname><given-names>C.</given-names></name><name><surname>Yin</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>Z.</given-names></name><etal/></person-group><article-title>Brucella suis vaccine strain 2 induces endoplasmic reticulum stress that affects intracellular replication in goat trophoblast cells in vitro</article-title><source>Frontiers in Cellular and Infection Microbiology</source><volume>6</volume><year>2016</year><fpage>19</fpage><pub-id pub-id-type="pmid">26904517</pub-id>
</element-citation>
      </ref>
      <ref id="bib128">
        <element-citation publication-type="journal" id="sref128"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Lin</surname><given-names>P.</given-names></name><name><surname>Yin</surname><given-names>Y.</given-names></name><name><surname>Zhou</surname><given-names>J.</given-names></name><name><surname>Lei</surname><given-names>L.</given-names></name><name><surname>Zhou</surname><given-names>X.</given-names></name><etal/></person-group><article-title>Brucella suis vaccine strain S2-infected immortalized caprine endometrial epithelial cell lines induce non-apoptotic ER-stress</article-title><source>Cell Stress &amp; Chaperones</source><volume>20</volume><year>2015</year><fpage>399</fpage><lpage>409</lpage><pub-id pub-id-type="pmid">25633898</pub-id>
</element-citation>
      </ref>
      <ref id="bib129">
        <element-citation publication-type="journal" id="sref129"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>S.</given-names></name><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>XI</surname><given-names>L.</given-names></name><name><surname>Cui</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>W.</given-names></name><etal/></person-group><article-title>A&#xA0;safe non-toxic Brucella abortus ghosts induce immune responses and confer protection in BALB/c mice</article-title><source>Molecular Immunology</source><volume>124</volume><year>2020</year><fpage>117</fpage><lpage>124</lpage><pub-id pub-id-type="pmid">32559678</pub-id>
</element-citation>
      </ref>
      <ref id="bib130">
        <element-citation publication-type="journal" id="sref130"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Tan</surname><given-names>D.</given-names></name><name><surname>Cai</surname><given-names>Y.</given-names></name><name><surname>Reinisch</surname><given-names>K.M.</given-names></name><name><surname>Walz</surname><given-names>T.</given-names></name><name><surname>Ferro-Novick</surname><given-names>S.</given-names></name></person-group><article-title>A&#xA0;requirement for ER-derived COPII vesicles in phagophore initiation</article-title><source>Autophagy</source><volume>10</volume><year>2014</year><fpage>708</fpage><lpage>709</lpage><pub-id pub-id-type="pmid">24561915</pub-id>
</element-citation>
      </ref>
      <ref id="bib131">
        <element-citation publication-type="journal" id="sref131"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Z.</given-names></name><name><surname>Wang</surname><given-names>G.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>Q.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Xie</surname><given-names>P.</given-names></name><etal/></person-group><article-title>Omp31 of Brucella inhibits NF-&#x3BA;B p65 signaling pathway by inducing autophagy in BV-2 microglia</article-title><source>Neurochemical Research</source><volume>46</volume><year>2021</year><fpage>3264</fpage><lpage>3272</lpage><pub-id pub-id-type="pmid">34536195</pub-id>
</element-citation>
      </ref>
      <ref id="bib132">
        <element-citation publication-type="journal" id="sref132"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>P.</given-names></name><name><surname>Cui</surname><given-names>G.</given-names></name><name><surname>Lu</surname><given-names>Q.</given-names></name><name><surname>Yang</surname><given-names>L.</given-names></name><name><surname>Guan</surname><given-names>Z.</given-names></name><name><surname>Sun</surname><given-names>W.</given-names></name><etal/></person-group><article-title>A20 promotes Brucella intracellular growth via inhibition of macrophage cell death and activation</article-title><source>Veterinary Microbiology</source><volume>175</volume><year>2015</year><fpage>50</fpage><lpage>57</lpage><pub-id pub-id-type="pmid">25433453</pub-id>
</element-citation>
      </ref>
      <ref id="bib133">
        <element-citation publication-type="journal" id="sref133"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>J.</given-names></name><name><surname>Zheng</surname><given-names>W.</given-names></name><name><surname>Chapman</surname><given-names>N.M.</given-names></name><name><surname>Geiger</surname><given-names>T.L.</given-names></name><name><surname>Chi</surname><given-names>H.</given-names></name></person-group><article-title>T&#xA0;cell metabolism in homeostasis and cancer immunity</article-title><source>Current Opinion in Biotechnology</source><volume>68</volume><year>2021</year><fpage>240</fpage><lpage>250</lpage><pub-id pub-id-type="pmid">33676144</pub-id>
</element-citation>
      </ref>
      <ref id="bib134">
        <element-citation publication-type="journal" id="sref134"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>H.S.</given-names></name><name><surname>Park</surname><given-names>K.</given-names></name><name><surname>Gola</surname><given-names>A.</given-names></name><name><surname>Baptista</surname><given-names>A.P.</given-names></name><name><surname>Miller</surname><given-names>C.H.</given-names></name><name><surname>Deep</surname><given-names>D.</given-names></name><etal/></person-group><article-title>A&#xA0;local regulatory T cell feedback circuit maintains immune homeostasis by pruning self-activated T cells</article-title><source>Cell</source><volume>184</volume><year>2021</year><fpage>3981</fpage><lpage>3997.e22</lpage><pub-id pub-id-type="pmid">34157301</pub-id>
</element-citation>
      </ref>
      <ref id="bib135">
        <element-citation publication-type="journal" id="sref135">
          <person-group person-group-type="author">
            <name>
              <surname>Wu</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Lei</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Xia</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Zhong</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>Q.</given-names>
            </name>
            <name>
              <surname>Shu</surname>
              <given-names>H.B.</given-names>
            </name>
          </person-group>
          <article-title>Regulation of TRIF-mediated innate immune response by K27-linked polyubiquitination and deubiquitination</article-title>
          <source>Nature Communications</source>
          <volume>10</volume>
          <year>2019</year>
          <fpage>4115</fpage>
        </element-citation>
      </ref>
      <ref id="bib136">
        <element-citation publication-type="journal" id="sref136">
          <person-group person-group-type="author">
            <name>
              <surname>Wu</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Xia</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Shin</surname>
              <given-names>W.J.</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>K.M.</given-names>
            </name>
            <name>
              <surname>Jung</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Herrmann</surname>
              <given-names>A.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Viral mimicry of interleukin-17a by SARS-CoV-2 ORF8</article-title>
          <source>mBio</source>
          <volume>13</volume>
          <year>2022</year>
          <object-id pub-id-type="publisher-id">e0040222</object-id>
        </element-citation>
      </ref>
      <ref id="bib137">
        <element-citation publication-type="journal" id="sref137">
          <person-group person-group-type="author">
            <name>
              <surname>Xia</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Yi</surname>
              <given-names>X.M.</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Shang</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Shu</surname>
              <given-names>H.B.</given-names>
            </name>
          </person-group>
          <article-title>PTPN1/2-mediated dephosphorylation of MITA/STING promotes its 20S proteasomal degradation and attenuates innate antiviral response</article-title>
          <source>Proceedings of the National Academy of Sciences of the U S A</source>
          <volume>116</volume>
          <year>2019</year>
          <fpage>20063</fpage>
          <lpage>20069</lpage>
        </element-citation>
      </ref>
      <ref id="bib138">
        <element-citation publication-type="journal" id="sref138">
          <person-group person-group-type="author">
            <name>
              <surname>Xiong</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Gu</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>J.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The VirB system plays a crucial role in Brucella intracellular infection</article-title>
          <source>International Journal of Molecular Sciences</source>
          <volume>22,13637</volume>
          <year>2021</year>
        </element-citation>
      </ref>
      <ref id="bib139">
        <element-citation publication-type="journal" id="sref139">
          <person-group person-group-type="author">
            <name>
              <surname>Xu</surname>
              <given-names>L.G.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Y.Y.</given-names>
            </name>
            <name>
              <surname>Han</surname>
              <given-names>K.J.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>L.Y.</given-names>
            </name>
            <name>
              <surname>Zhai</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Shu</surname>
              <given-names>H.B.</given-names>
            </name>
          </person-group>
          <article-title>VISA is an adapter protein required for virus-triggered IFN-beta signaling</article-title>
          <source>Molecules and Cells</source>
          <volume>19</volume>
          <year>2005</year>
          <fpage>727</fpage>
          <lpage>740</lpage>
        </element-citation>
      </ref>
      <ref id="bib140">
        <element-citation publication-type="journal" id="sref140"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>X.</given-names></name><name><surname>He</surname><given-names>Z.</given-names></name><name><surname>Zhang</surname><given-names>G.</given-names></name><name><surname>Lu</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Ren</surname><given-names>H.</given-names></name><etal/></person-group><article-title>Evaluation of reactivity of monoclonal antibodies against Omp25 of Brucella spp</article-title><source>Frontiers in Cellular and Infection Microbiology</source><volume>10</volume><year>2020</year><fpage>145</fpage><pub-id pub-id-type="pmid">32373546</pub-id>
</element-citation>
      </ref>
      <ref id="bib141">
        <element-citation publication-type="journal" id="sref141">
          <person-group person-group-type="author">
            <name>
              <surname>Yang</surname>
              <given-names>Q.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>T.T.</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Wei</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Luo</surname>
              <given-names>W.W.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>TRIM32-TAX1BP1-dependent selective autophagic degradation of TRIF negatively regulates TLR3/4-mediated innate immune responses</article-title>
          <source>PLoS Pathogens</source>
          <volume>13</volume>
          <year>2017</year>
          <object-id pub-id-type="publisher-id">e1006600</object-id>
        </element-citation>
      </ref>
      <ref id="bib142">
        <element-citation publication-type="journal" id="sref142">
          <person-group person-group-type="author">
            <name>
              <surname>Yi</surname>
              <given-names>X.M.</given-names>
            </name>
            <name>
              <surname>Lian</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Signaling and functions of interleukin-33 in immune regulation and diseases</article-title>
          <source>Cell Insight</source>
          <volume>1</volume>
          <year>2022</year>
          <object-id pub-id-type="publisher-id">100042</object-id>
        </element-citation>
      </ref>
      <ref id="bib143">
        <element-citation publication-type="journal" id="sref143">
          <person-group person-group-type="author">
            <name>
              <surname>Yin</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Eisenbarth</surname>
              <given-names>S.C.</given-names>
            </name>
          </person-group>
          <article-title>Dendritic cell regulation of T helper cells</article-title>
          <source>Annual Review of Immunology</source>
          <volume>39</volume>
          <year>2021</year>
          <fpage>759</fpage>
          <lpage>790</lpage>
        </element-citation>
      </ref>
      <ref id="bib144">
        <element-citation publication-type="journal" id="sref144"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Guo</surname><given-names>F.</given-names></name><name><surname>Chen</surname><given-names>C.</given-names></name><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>Brucella melitensis 16M&#x394;hfq attenuation confers protection against wild-type challenge in BALB/c mice</article-title><source>Microbiology and Immunology</source><volume>57</volume><year>2013</year><fpage>502</fpage><lpage>510</lpage><pub-id pub-id-type="pmid">23647412</pub-id>
</element-citation>
      </ref>
      <ref id="bib145">
        <element-citation publication-type="journal" id="sref145"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>K.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Guo</surname><given-names>F.</given-names></name><name><surname>Yuan</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>W.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>OMP31 of Brucella melitensis 16M impairs the apoptosis of macrophages triggered by TNF-&#x3B1;</article-title><source>Experimental and Therapeutic Medicine</source><volume>12</volume><year>2016</year><fpage>2783</fpage><lpage>2789</lpage><pub-id pub-id-type="pmid">27698784</pub-id>
</element-citation>
      </ref>
      <ref id="bib146">
        <element-citation publication-type="journal" id="sref146"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Yin</surname><given-names>S.</given-names></name><name><surname>Yi</surname><given-names>D.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Guo</surname><given-names>F.</given-names></name><etal/></person-group><article-title>The Brucella melitensis M5-90&#x394;manB live vaccine candidate is safer than M5-90 and confers protection against wild-type challenge in BALB/c mice</article-title><source>Microbial Pathogenesis</source><volume>112</volume><year>2017</year><fpage>148</fpage><lpage>155</lpage><pub-id pub-id-type="pmid">28916316</pub-id>
</element-citation>
      </ref>
      <ref id="bib147">
        <element-citation publication-type="journal" id="sref147"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Shao</surname><given-names>X.</given-names></name><name><surname>Wu</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Outer membrane protein 25 of Brucella activates mitogen-activated protein kinase signal pathway in human trophoblast cells</article-title><source>Frontiers in Veterinary Science</source><volume>4</volume><year>2017</year><fpage>197</fpage><pub-id pub-id-type="pmid">29326948</pub-id>
</element-citation>
      </ref>
      <ref id="bib148">
        <element-citation publication-type="journal" id="sref148">
          <person-group person-group-type="author">
            <name>
              <surname>Zhang</surname>
              <given-names>Z.D.</given-names>
            </name>
            <name>
              <surname>Zhong</surname>
              <given-names>B.</given-names>
            </name>
          </person-group>
          <article-title>Regulation and function of the cGAS-MITA/STING axis in health and disease</article-title>
          <source>Cell Insight</source>
          <volume>1</volume>
          <year>2022</year>
          <object-id pub-id-type="publisher-id">100001</object-id>
        </element-citation>
      </ref>
      <ref id="bib149">
        <element-citation publication-type="journal" id="sref149">
          <person-group person-group-type="author">
            <name>
              <surname>Zhang</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Zhong</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Qin</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Zhi</surname>
              <given-names>F.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Integrated proteomic and transcriptomic analyses reveal the roles of Brucella homolog of BAX inhibitor 1 in cell division and membrane homeostasis of Brucella suis S2</article-title>
          <source>Frontiers in Microbiology</source>
          <volume>12</volume>
          <year>2021</year>
          <object-id pub-id-type="publisher-id">632095</object-id>
        </element-citation>
      </ref>
      <ref id="bib150">
        <element-citation publication-type="journal" id="sref150">
          <person-group person-group-type="author">
            <name>
              <surname>Zheng</surname>
              <given-names>Z.Q.</given-names>
            </name>
            <name>
              <surname>Fu</surname>
              <given-names>Y.Z.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>S.Y.</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>Z.S.</given-names>
            </name>
            <name>
              <surname>Zou</surname>
              <given-names>H.M.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Y.Y.</given-names>
            </name>
          </person-group>
          <article-title>Herpes simplex virus protein UL56 inhibits cGAS-Mediated DNA sensing to evade antiviral immunity</article-title>
          <source>Cell Insight</source>
          <volume>1</volume>
          <year>2022</year>
          <object-id pub-id-type="publisher-id">100014</object-id>
        </element-citation>
      </ref>
      <ref id="bib152">
        <element-citation publication-type="journal" id="sref152">
          <person-group person-group-type="author">
            <name>
              <surname>Zhong</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Feng</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>W.H.</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Ding</surname>
              <given-names>Y.D.</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>Y.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The zinc-finger protein ZFYVE1 modulates TLR3-mediated signaling by facilitating TLR3 ligand binding</article-title>
          <source>Cell Molecular Immunology</source>
          <volume>17</volume>
          <year>2020</year>
          <fpage>741</fpage>
          <lpage>752</lpage>
        </element-citation>
      </ref>
      <ref id="bib151">
        <element-citation publication-type="journal" id="sref151"><person-group person-group-type="author"><name><surname>Zhi</surname><given-names>F.</given-names></name><name><surname>Zhou</surname><given-names>D.</given-names></name><name><surname>Bai</surname><given-names>F.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Xiang</surname><given-names>C.</given-names></name><name><surname>Zhang</surname><given-names>G.</given-names></name><etal/></person-group><article-title>VceC mediated IRE1 pathway and inhibited CHOP-induced apoptosis to support Brucella replication in goat trophoblast cells</article-title><source>International Journal of Molecular Sciences</source><volume>20</volume><year>2019</year><fpage>4104</fpage><pub-id pub-id-type="pmid">31443507</pub-id>
</element-citation>
      </ref>
      <ref id="bib153">
        <element-citation publication-type="journal" id="sref153"><person-group person-group-type="author"><name><surname>Zhong</surname><given-names>B.</given-names></name><name><surname>Tien</surname><given-names>P.</given-names></name><name><surname>Shu</surname><given-names>H.B.</given-names></name></person-group><article-title>Innate immune responses: Crosstalk of signaling and regulation of gene transcription</article-title><source>Virology</source><volume>352</volume><year>2006</year><fpage>14</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">16753195</pub-id>
</element-citation>
      </ref>
      <ref id="bib154">
        <element-citation publication-type="journal" id="sref154"><person-group person-group-type="author"><name><surname>Zhong</surname><given-names>B.</given-names></name><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>Y.Y.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Diao</surname><given-names>F.</given-names></name><etal/></person-group><article-title>The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor activation</article-title><source>Immunity</source><volume>29</volume><year>2008</year><fpage>538</fpage><lpage>550</lpage><pub-id pub-id-type="pmid">18818105</pub-id>
</element-citation>
      </ref>
      <ref id="bib155">
        <element-citation publication-type="journal" id="sref155"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>L.</given-names></name><name><surname>Feng</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>G.</given-names></name><name><surname>Jiang</surname><given-names>H.</given-names></name><name><surname>Zhang</surname><given-names>Z.</given-names></name><name><surname>Wang</surname><given-names>N.</given-names></name><etal/></person-group><article-title>Brucella suis strain 2 vaccine is safe and protective against heterologous Brucella spp. infections</article-title><source>Vaccine</source><volume>34</volume><year>2016</year><fpage>395</fpage><lpage>400</lpage><pub-id pub-id-type="pmid">26626213</pub-id>
</element-citation>
      </ref>
    </ref-list>
    <ack id="ack0010">
      <title>Acknowledgments</title>
      <p id="p0135">This work was supported by grants from the <funding-source id="gs1">Basic Research Program-Natural Science Foundation of Gansu province</funding-source> (23JRRA561) and also supported by the <funding-source id="gs2">Joint Scientific Research Fund Key Projects of Gansu province, China</funding-source> (23JRRA1517).</p>
    </ack>
  </back>
</article>
</pmc-articleset>